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All heme thiolate enzymes have conserved hydrogen bonding networks 
surrounding the axial thiolate ligand. In order to understand the role of this proximal 
hydrogen bonding network in nitric oxide synthases (NOS), three mutants of the NOS 
enzyme from Geobacillus stearothermophilus were expressed and characterized. The wild 
type enzyme has a tryptophan residue at position 70 that π-stacks with the porphyrin ring 
and donates a long hydrogen-bonding interaction to the thiolate ligand of the heme iron. 
The native Trp was replaced with His, Phe, and Tyr. These three residues were selected to 
investigate the two effects of the Trp, H-bonding and π-stacking. Several different 
spectroscopic techniques were used to investigate the stability and properties of these 
mutant enzymes. The identity of each mutant was confirmed by mass spectrometry. Both 
UV-visible absorption and circular dichroism spectroscopies were used to assess the 
stability of the new proteins. It was shown using binding assays, generation of the ferrous-
CO species, and redox titrations that the σ-donating abilities of the thiolate are increased 
after removal of the hydrogen bonding group in the Trp. Finally, electron paramagnetic 
resonance spectroscopy and Evans method nuclear magnetic resonance spectroscopy were 
used to characterize the spin state of the iron center in each mutant, reflecting the increased 
σ-donating capabilities of the thiolate upon removal of the hydrogen bonding group. The 
reduction potential of wild type and W70H were determined by chemical titration to be       
-362 and -339 mV vs. NHE, respectively. This is the first report of the reduction potential 
of any bacterial nitric oxide synthase. 
The reactivity of each the wild type enzyme and the three new mutants was tested 
using stopped-flow mixing coupled with UV-visible absorption spectroscopy and the 
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Griess Assay. Autoxidation rates measured by stopped-flow suggest that the Tyr and Phe 
mutants do indeed have significantly more negative reduction potentials, but that the His 
mutant is particularly slow to oxidize. The Griess Assays showed that all four enzymes 
produce nitrite in solution, when provided with substrate, cofactor and hydrogen peroxide 
(as a source of reducing equivalents). In single turnover experiments, however, only three 
of the four enzymes showed evidence of ferric-NO production. The His mutant showed no 
intermediate absorbance near 440 nm (which would be indicative of ferric-NO formation), 
suggesting that it releases NO- rather than the radical species NO·. The role of this 
hydrogen bond is concluded to be an electronic one, rather than playing any part in 
positioning the heme. It prevents formation of the inactive P420 species, and tunes the 
reduction potential to one high enough to be reduced by a reductase but low enough to still 
deliver an electron to the redox active cofactor, tetrahydrobiopterin, at the end of catalysis.   
The rate at which NO is released by each NOS enzyme varies greatly among 
isoforms and species, over nearly two orders of magnitude. One residue (an isoleucine 
located above the heme in bacterial enzymes) involved in the gating of NO release has been 
previously identified by Stuehr. However, this single residue does not account for the 
entirety of the differences among the forms of NOS. Another residue, a histidine at position 
134 in NOS from Geobacillus stearothermophilus (gsNOS), was hypothesized to also 
participate in gating NO release based on an observed correlation between rates of NO 
release and the bulk of side chains at this position. Each single point mutation, H134S and 
I223V, and the double mutant were expressed in gsNOS and their reactivity toward the 
diatomic molecules CO and NO were studied. CO rebinding was investigated using laser 
flash photolysis and NO release using stopped flow UV-visible spectroscopy. The presence 
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of both monomer and dimer was observed in solution, and position 134 was shown to be 
another key residue in gating NO release. Wild type gsNOS contains both the bulkier 
Ile223 and His134 and has the slowest measured NO release (0.039 s-1) of all NOS 
enzymes. A new, more accurate kinetics model for turnover is proposed. Each single 
mutation increased NO release substantially, while the double mutant has a rate constant of 
1.0 s-1, nearly as fast as mammalian iNOS at 2.3 s-1, identifying position 134 as another 
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C h a p t e r  1  
 
 




1.1 Nitric Oxide Synthases 
Salvador Moncada and colleagues reported in 1987 that the molecule responsible 
for relaxation of blood vessels is nitric oxide (NO).1 This publication marked the 
beginning of a new area of chemical and biological research, now with thousands of 
articles published each year. Long known as a cytotoxic agent in pathological processes 
and a major component of smog, NO is now recognized as a key signaling molecule in 
the cardiovascular, immune, and nervous systems.2  
 Nitric oxide synthases (NOSs) are responsible for the production of NO in living 
systems.3 The three (mammalian) isoforms of the enzyme are named for the tissues in 
which they are found: endothelial NOS (eNOS), neuronal (nNOS), and an inducible form 
found in macrophages (iNOS).4 NOS enzymes have been identified in some bacterial 
species as well, such as Bacillus subtilis and Sorangium cellulosum.5-6 NOS catalyzes the 
oxidation of L-arginine (Arg) to L-citrulline in two turnovers, with N-hydroxy- L-arginine 
(NOHA) as an enzyme-bound intermediate (the product of the first turnover). The overall 
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1.2 Mechanism of NO Production 
Arginine is oxidized to nitric oxide in two full turnovers, through the intermediate 
N-hydroxy-L-arginine. The intermediate actually has a higher binding affinity than 
arginine, preventing it from leaving the binding pocket, where it is positioned above the 
heme.16 The first turnover is a two-electron oxidation of substrate, formally a 
hydroxylation of one of the guanidinium nitrogens.2 The stoichiometry of this reaction is 
identical to that of hydroxylations carried out by the extensively-studied cytochromes 
P450.17-18 The second reaction, however, is unique in biology. The use of the 
tetrahydrobiopterin in a redox-active manner (Scheme 1.3) is unique to NOS. Also, the 
second turnover is formally a three-electron oxidation of NOHA to citrulline and NO, 
specifically the radical species and not any other nitrogen oxide.3  
The mechanism of NO production is not completely understood. The resting state 
of the enzyme is a six-coordinate ferric heme with a water molecule occupying the sixth 
ligand position (four positions are occupied by N donors from the porphyrin and one by a 
sulfur atom from an axial cysteine, Cys194).8 Although neither Arg nor NOHA ligates 
the heme, substrate binding shifts both the Soret absorption maximum and the heme spin 
state. The presence of substrate in the binding pocket sterically excludes water, forcing a 
high-spin five-coordinate heme complex.18 One-electron reduction of the NOS:substrate 
complex gives a five-coordinate ferrous heme that readily binds dioxygen, forming a 
ferrous-oxy species (equivalent to ferric superoxide), the last observed intermediate in the 
catalytic cycle.19   
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The role of pterin has been extensively investigated. This molecule binds in a 
pocket alongside the heme, forming a hydrogen bond with a protoporphyrin-IX 
carboxylate, thereby coupling it to the active site.20 It is known that a pterin-based radical 
forms and is reduced during the catalytic cycle, as determined by analysis of results from 
rapid-freeze EPR experiments.21-23 Production of NO has never been observed without 
fully reduced pterin cofactor, such conditions produce cyano-ornithine and nitrite rather 
than citrulline and NO.13    
The NOS reaction cycle bears many similarities to that of cytochromes P450 (cyt. 
P450). Cyt. P450s contain thiolate-heme active sites and hydroxylate substrates via two-
electron oxidation processes.18 The cyt. P450 cycle also begins with substrate binding 
followed by heme reduction, dioxygen binding, and another reduction step leading to the 
formation of a high-valent iron-oxo complex (Compound I) that hydroxylates the 
substrate (Scheme 1.3). Separate enzymes serve as reductases for most cyt. P450s, but 
substrate hydroxylation can be driven using external sources of electrons.17 It is of note 
that one cytochrome P450 has been found with an attached reductase domain: cyt. P450 
BM3.24 The reductase domain of this enzyme also shuttles electrons from NADPH 
through two flavins to the heme cofactor just like mammalian NOS, although it does not 
need to dimerize to function as NOS does. Owing to these similarities, the mechanism of 
the first turnover of NOS is postulated to be the same as that of cyt. P450s. However, the 
second turnover, a three-electron oxidation, is thought to employ a unique mechanism.25 
It has been suggested that a protonated ferric hydroperoxide may act as the nucleophile in 
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mutagenesis nearly impossible (one was replaced by a proline residue, removing the 
amide group, but also shifting an entire loop within the protein, confusing results).  
Steps in the mechanistic cycle borrowed from cyt. P450 are shown in Scheme 1.3.  
Although several intermediates in the cyt. P450 cycle already have been observed, there 
can be no doubt that “the hunt for an unambiguous experimental identification of the 
ephemeral active oxygen species will most certainly continue”.29 In fact, after several 
decades of research on cyt. P450s it was only within the past year that the elusive, high-
valent Compound I was positively characterized and shown to be the active 
hydroxylating oxidant.30 If that is the case for cyt. P450, then we may conclude that work 
on the NOS catalytic cycle is just beginning.  
 
1.3 Bacterial Nitric Oxide Synthases 
 The function of inducible nitric oxide synthase in mammalian macrophage cells is 
predominantly to kill the cells of invading bacteria by pumping them full of nitric 
oxide.10 NO is a radical species and therefore reacts rapidly with many parts of cells 
causing extensive damage. Given its usefulness in killing bacterial cells, it was surprising 
when researchers discovered NO synthase-like proteins in prokaryotic systems in the 
early 2000s.31-32 Since then, NOS-like proteins have been identified in all kingdoms of 
life, with examples in archaea and bacteria, emphasizing their biological importance.5 
Their presence in several pathogenic species is of particular interest. The bacterial NO 
synthases from three phyla of Gram-positive bacteria (actinobacter, deinococcus, and 
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 There are also, however, some striking differences between bacterial and 
eukaryotic systems. The largest difference is that only one bacterial NOS (bNOS) has 
been identified to date that contains a fused reductase domain within its amino acid 
sequence.35 Nearly all bNOS enzymes are made up of only the oxygenase domain where 
the chemistry of NO production occurs (the NOS from Sorangium cellulosum being the 
only exception). This raises the question of how reducing equivalents can be delivered. 
bNOS is also missing a zinc-binding loop contained in all the mammalian isoforms. This 
loop is necessary for the dimerization of mammalian systems, a requirement for function 
because a reductase domain from one monomer of enzyme provides the reducing 
equivalents for the oxygenase domain of the other monomer.36 Truncation of the peptide 
chain in order to remove this loop results in the abolishment of catalytic activity. This 
loop partially obstructs the pterin cofactor binding site, protecting it from solvent.37 Some 
bacteria cannot synthesize tetrahydrobiopterin, they simply lack the necessary sequences 
in their genomes.6 It has been proposed that removal of this loop allows room to 
accommodate the larger pterin, tetrahydrofolate, which all these bacteria are able to 
synthesize.5 The final major difference is a single point mutation near the heme. This 
position is a conserved valine among eukaryotic systems, while in bacteria it is an 
isoleucine.38 It has been shown previously that this residue, situated right above the iron 
atom and within Van der Waals contact distance of Fe-NO species (Ile), affects the rate 
of NO release from the enzyme.39 These differences may highlight key functional 
differences among species.  
 Given these few but striking differences, it was necessary to prove that bacterial 
NO synthase-like proteins did in fact produce nitric oxide, and using the same chemistry 
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as their eukaryotic counterparts. One landmark study required the collaboration of three 
groups, those of Stephen Lippard, Dennis Stuehr and Evgeny Nudler.33 It is a 
complicated process to definitively prove that an enzyme functions and produces NO, not 
any other species, in vivo. In oxygenated aqueous solution, NO is oxidized rapidly to 
nitrite and nitrate. Reagents have been developed that can colorimetrically detect these 
NO metabolites in solution (Griess Assay, Cayman Chemicals). As NO transforms to 
NO2- and NO3- in solution, the concentration of these in solution is proportional to the 
amount of NO produced.34 This team of researchers used both the Griess Assay to detect 
NO in the extracellular environment of the cells of B. subtillus and B. anthracis and an 
NO-specific fluorescent probe called CuFL that allows for intracellular NO detection. 
These techniques, in combination with creative use of an arabinose promoter, allowed 
them to prove that NO is indeed produced in these cells by their NOS enzymes.  
 The demonstration of NO synthesis within bacterial cells raises the question of 
why NO is produced.6 The signaling functions of NO in eukaryotic systems are mediated 
by the NO receptor, soluble guanylate cyclase (sGC).40 A bacterial homolog of sGC has 
been identified as a family of H-NOX proteins found by Michael Marletta and 
coworkers.41 Interestingly, though, no H-NOX protein has been found in the genome of 
any bacteria that also code for NOS.42 No other NO receptors have been identified. It has 
been proposed that in pathogenic bacteria the synthesis of NO promotes resistance to 
oxidative stress caused by the host immune system.43 NO may also promote antibiotic 
resistance, due to its ability to chemically modify many compounds used as antibacterial 
agents.44 While these hypotheses may explain the role of NO in pathogenic strains such 
13 
 
as Staphylococcus aureus and Bacillus anthracis, the role of NO in non-pathogenic 
bacteria remains a mystery.   
 The NOS (gsNOS) from a non-pathogenic bacterial thermophile, Geobacillus 
stearothermophilus, is the focus of this majority of this work. Only one chapter deals 
with the mammalian inducible isoform, the rest focus on this unique bacterial enzyme. 
gsNOS is noted for the particularly stable ferrous-oxy complex it forms.34 This complex 
lasts only a few seconds at most in other enzymes, but is stable on the order of a minute 
in gsNOS at 4 °C. It is not incredibly surprising that the kinetics of this enzyme are 
slower at standard temperatures than other enzymes, given it comes from a thermophilic 
organism and must function properly at significantly elevated temperatures. It is this 
stability that makes this a useful system to study. This enzyme was originally expressed, 
characterized, and crystallized by Brian Crane and coworkers at Cornell.34 The protein 
fold as revealed by X-ray crystallography is shown in Figure 1.3, with a close-up on the 
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1.4 An Interest in Heme-Thiolates 
 The Gray group has had a long-standing interest in heme-thiolate systems, 
specifically high-valent iron-oxo species long believed (and only recently proven) to be 
the active hydroxylating species in cytochromes P450. Our work on high-valent iron 
hemes actually began in the mid to late 1990s.  The group had developed a technique 
called flash/quench, a general scheme of which is shown in Scheme 1.4.45 In this process, 
a photosensitizer such as ruthenium(II) tris(2,2’-bipyridine (or bpy)) is excited by 
illumination with visible light (into its metal to ligand charge transfer band) creating an 
excited state with a lifetime of more than 600 µs (the flash). Interestingly, this excited 
state has a significant driving force to either gain or lose an electron, about 0.8 V.46 In the 
presence of another reactant, such as ruthenium(III) hexaammine, the excited state reacts 
(is quenched) to form Ru(II) hexaammine and Ru(III)(bpy)3. This Ru(III)(bpy)3 species is 
an incredibly potent oxidant, with a driving force of nearly 1.3 V (in aqueous solution). 
Not only does flash/quench provide a more potent reactant, but often the further 
separation of charges produces a longer lifetime for the oxidizing species, allowing more 
time for the desired reaction to occur. (This same flash/quench scheme can be performed 
using a reductive quencher such as octacyano molybdate to produce the strong reductant 
Ru(I)(bpy)3.)  
Both reversible and irreversible quenchers can be used. In reversible systems, the 
quencher eventually reacts with either Ru(III) or another oxidized species to reform all of 
the original species in their resting oxidation states. For irreversible systems, once the 
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to form an oxidized, formally Fe(IV) species. Both Compound II (ferryl) and Compound 
I (ferryl + porphyrin radical cation) were observed. This process was repeated with the 
enzyme horse radish peroxidase (HRP).48 With this system, and irreversible oxidative 
quencher was needed in order to afford enough time to transfer an electron from the heme 
center to the Ru(III) species. The characterization of these species furthered our 
understanding of their catalytic cycle.  
 The group then wished to extend this process to generate high-valent iron species 
in more complex systems, particularly cytochromes P450. Unfortunately, this afforded no 
detectable reaction. In fact, the use of irreversible quenchers led only to the degredation 
of their protein systems. The highly oxidized Ru(III) will find something to react with, 
even if it cannot perform the desired reaction with the iron, effectively leading to 
oxidative destruction of the protein.   
 In an effort to observe these elusive high-valent species in a cyt. P450, the group 
then began developing what later came to be called “wires”. Wires are modified 
photosensitizers, similar to the traditional Ru(bpy)3 but with an additional component.49 
In examining the crystal structures of HRP and cyt. P450s, it became clear that while the 
heme of HRP was exposed to solvent (and therefore solution) on one edge, the heme of 
cyt. P450 was completely buried by the protein backbone. Researchers needed a way to 
promote interaction between the photosensitizer and the active site. The second 
component of these wires addressed this issue of coupling to the protein by attaching a 
tail group to the photosensitizer head (Figure 1.4). The tail group typically resembled the 
substrate of the particular cyt. P450 under study, bringing the Ru moiety closer to the 
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particular there remain many questions about the exact mechanism by which NO is 
produced.  
 
1.5 Tools of the Bioinorganic Chemist 
 The ultimate goal of the work presented herein is to further our understanding of 
the catalytic cycle of nitric oxide synthases in particular and heme-thiolates in general. 
There are many techniques for characterizing a metalloenzyme and its mechanism, even 
beyond those previously used by our group. One technique of great use to the Gray group 
is electronic absorption spectroscopy (UV-vis). This technique is particularly useful in 
the case of heme enzymes due to their characteristic absorption bands in the visible 
region of the electromagnetic spectrum. Both the Soret band and the Q bands are 
sensitive to oxidation state and ligation of the iron.18 Several examples of various 
common oxidation states with typical axial ligation (the sixth position, other than the four 
coordinating porphyrin nitrogens and the axial cysteine ligands) are shown in Figure 1.5. 
Shifts in Soret position (the intense band near 400 nm) are significant enough to allow a 
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determine an exact reduction potential and cyclic voltammetry to learn about the kinetics 
of such systems. These are just a few of the techniques available to a modern 
bioinorganic chemist, and such techniques will be introduced and explained further as 
they are used in the following work.  
The final, but possibly most important, tool available to enzymologists (and 
chemists) today is site-directed mutagenesis. This process (awarded the Nobel Prize in 
Chemistry in 1993) allows researchers to select particular amino acids within a protein’s 
sequence and change them into another amino acid, through creative use of primers and 
the polymerase chain reaction (PCR). Proteins can now be investigated and modified on 
the atomic level.  
 
1.6 Conclusion 
These techniques were used to investigate the nitric oxide synthase from 
Geobacillus stearothermophilus and its reactivity, with the goal of furthering our general 
understanding of NOS enzymes and their mechanism of NO production. This particular 
system provides stability not present in other NOSs and can be expressed in high yields 
in Escherichia coli in the lab (8 mg/L). Investigations were made into the nature of the 
heme active site and its reactivity.  
This was done using two sets of mutant enzymes. The first set of mutants was 
designed to perturb the hydrogen bonding to the axial thiolate ligand. The native Trp was 
replaced in turn with His (which can still H-bond but cannot π-stack with the porphyrin), 
Phe (which can π-stack but not H-bond) and Tyr (again it can π-stack but not H-bond, but 
the hydroxylate group greatly alters its electronics). These mutants were analyzed using 
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various bioinorganic techniques, compared with the wild type, and used to learn about the 
tuning of the heme cofactor for the exact reactivity of NOSs.  
The second set of mutants was made to investigate rates of NO release from the 
enzyme, once produced during catalysis. Different cellular functions of NO would 
require different rates of NO production and release.2 It has been observed that two 
particular positions may be involved in gating NO release (positions 134 and 223 in 
gsNOS). Mutations were made to vary the bulk of side chains at these positions, and their 
rates of NO release and interactions with the diatomic mimic carbon monoxide (CO) 
were measured in detail. This thesis covers the work done investigating these two sets of 
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J. R. Winkler, H. B. Gray. Nanosecond photoreduction of inducible nitric oxide synthase 
by a Ru-diimine electron tunneling wire bound distant from the active site. J. Inorg. 





2.1 Abstract   
The Gray group has been studying electron transfer in protein systems for the past 
three decades. During this time a vast amount of information has been collected 
concerning the nature of the protein matrix and its ability to facilitate such charge transfer 
reactions. This led to the development of techniques for the covalent attachment of 
photosensitizers to metalloproteins, and later to the development of compounds 
consisting of sensitizers linked to substrates (dubbed “wires”) in order to promote 
interactions between the photosensitizer and the metal active site buried deep within the 
protein. A Ru-diimine wire, [(4,4’,5,5’-tetramethylbipyridine)2Ru(F9bp)]2+ (tmRu-F9bp, 
where F9bp is 4-methyl-4’-methylperfluorobiphenylbipyridine), binds tightly to the 
oxidase domain of inducible nitric oxide synthase (iNOSoxy). The binding of tmRu-F9bp 
is independent of tetrahydrobiopterin, arginine, and imidazole, indicating that the wire 
resides on the surface of the enzyme, distant from the active-site heme. Photoreduction of 
an imidazole-bound active-site heme iron in the enzyme-wire conjugate (kET = 2(1) × 107 
s-1) is fully seven orders of magnitude faster than the in vivo process. Wires such as this 
surface-binding example are used to study the various electron transfer processes in 
metalloenzymes in an effort to generate and characterize reactive intermediate species 
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Electron transfers occur from one redox active compound to another. In biological 
systems these are commonly flavins, quinones, porphyrins, and metal centers. Nature 
developed protein scaffolds in order to insulate these redox sites from one another, 
preventing deleterious side reactions and promoting only the specific reaction of choice. 
The very nature of these protein scaffolds is designed to inhibit the random transfer of 
charge, making electron transfer difficult. The physical presence of the scaffold separates 
the two species participating in electron transfer. Without these scaffolds, species would 
simply move toward the thermodynamically favored state and cells would stop 
functioning. Particular reactions are desired, however, and therefore the protein must 
somehow also facilitate these vital charge transfers over large distances (sometimes 
greater than 20 Å). The Gray group has long been interested in understanding how 
proteins mediate these long-range electron transfer reactions.  
A very powerful theory for studying and understanding electron transfer (ET) 
reactions has been developed by the Caltech professor Rudy Marcus. While, originally 
developed with simpler systems in mind, this theoretical formalism has proven applicable 
in protein systems and provides a context within which ET in metalloproteins can be 
studied.       
Semi-Classical Marcus Theory 
Marcus Theory is a formalism through which electron transfer reactions can be 
understood.3-4 It relies on the Franck-Condon Principal which states that when a molecule 
absorbs a photon the rearrangement of electrons is nearly instantaneous (occurs over the 
femtosecond timescale).4 However, the nuclei of the constituent atoms are much heavier 
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uncomplexed photogenerated oxidants were not successful so we changed course, as 
discussed in the following paragraphs.  
Since 1999, we have developed sensitizer-linked electron tunneling wires that are 
able to deliver electrons and holes rapidly to and from deeply buried active sites of heme 
enzymes.16 Attachment of the photosensitizer to the substrate promotes a close interaction 
between the two and increases the probability of electron transfer by increasing coupling 
(HAB) (Figure 2.4).   This technique proved very useful with cytochromes P450 and 
enabled the characterization of the enzyme in two states, open and closed as well as 
transient generation of a reduced state. These heavy-metal containing wires can actually 
promote crystallization of protein samples and provide a second transition metal besides 
the heme iron to aid in solving crystal structures. A selection of such molecules 
developed for the oxygenase domain of iNOS (iNOSoxy) is shown in Table 2.1.  
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this transformation in two turnovers, producing NG-hydroxy-L-arginine (NHA) as an 
enzyme-bound intermediate, requiring three electrons from its reductase domain. Each 
turnover is expected to proceed through a mechanism similar to that of cytochrome P450 
(although the two turnovers may utilize a different species for substrate oxidation), 
central to which are two slow electron transfer (ET) events.12, 18-22 The first ET event 
reduces the resting, substrate-bound heme to the ferrous state, which then binds oxygen 
to create the last observable intermediate (ferric-superoxo).20, 23 It is thought that the 
second ET event, where the electron is supplied by the cofactor tetrahydrobiopterin 
(BH4), produces one or more high-valent heme species, with substrate oxidation possibly 
occurring from a ferryl-porphyrin+˙ intermediate (Compound I).20, 24 The sluggishness of 
the second ET step, however, has so far prevented the characterization of high-valent 
intermediates in the catalytic cycle in solution.12, 20, 25 Cryoreduction of the heme domain 
of ferric-superoxo endothelial NOS at 77 K leads to the formation of a ferric-peroxo 
species.12 Annealing at 165 K results in conversion to the product state without the 
appearance of intermediates. These data suggest that O-O bond cleavage is slower than 
reaction with substrate.   
 By employing laser-induced ET to reduce the active-site heme very rapidly, it 
should be possible to observe high-valent intermediates that follow in the catalytic cycle. 
Toward this end, we and others have developed photoactive electron tunneling wires to 
deliver electrons and holes to and from the deeply buried heme active sites in P450cam8, 
26-27 and NOS.16, 28-30 Importantly, one of the NOS wires, tmRu-F9bp (Scheme 2.4), can 
potentially probe the catalytic cycle, since it binds tightly and specifically to the oxidase 
domain of the inducible form of the enzyme (iNOSoxy) in a region that is distant from 
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the active site.17 Here we demonstrate that an imidazole-ligated heme in tmRu-
F9bp:iNOSoxy can be photoreduced several million times faster (kET = 2(1) × 107 s-1) 
than the physiological ET reaction.  
 
 




2.3 Materials and Methods 
General   
The tmRu-F9bp complex was synthesized as described previously.8-9, 31 
Tetramethylphenylenediamine (TMPD) was obtained from Aldrich and vacuum-
sublimed before use. Tetrahydrobiopterin (BH4, Aldrich) was stored under argon at -20 
°C. All other chemicals were used as received from Sigma, JT Baker, Fischer, EM 
Sciences, and Mallinckrodt. UV-visible absorption spectra were acquired on an Agilent 
8453 UV-visible spectrophotometer. Gel electrophoresis was run on a Phast System 
(Pharmacia) with 8–25 percent gradient precast agarose gels and SDS buffer strips. 
Samples were loaded in 4x SDS buffer and stained with Coomassie blue. Samples were 






















iNOSoxy Expression and Purification   
The heme domain of iNOS with a C-terminal His6 tag was overexpressed in E. 
coli and purified as described previously 32 with several exceptions. Briefly, expression 
cells were subjected to two rounds of chemical lysis by pelleting and resuspension in 40 
mL of B-PER lysis buffer (protein extraction reagent B, Pierce). The lysis buffer included 
a cocktail of protease inhibitors (10 μg/mL benzamidine, 5 μg/mL leupeptin, 1 μg/mL 
each pepstatin, antipain, and chymostatin, and ~ 500 μM Pefabloc (Roche)) as well as 
100 μg/mL DNase, 100 μg/mL RNase, ~ 500 μg/mL lysozyme, and 20 mM imidazole per 
liter of cells. The suspension was centrifuged and the supernatant was loaded directly 
onto a His6 immobilized metal-ion affinity chromatography column (5 mL Ni2+:HisTrap, 
Amersham). Once the protein was completely loaded, it was washed with 20 column 
volumes of 20 mM imidazole in 50 mM NaPi/300 mM NaCl/pH 8. The protein was 
eluted with 150 mM imidazole and concentrated to ~ 3 mL in an Amicon Ultra 
centrifugation device (10,000 MWCO, Millipore). The concentrated sample was then 
further purified over a size-exclusion column, as described previously.32 The anion 
exchange column was omitted when ≥ 95 percent purity was confirmed by UV-visible 
spectroscopy and gel electrophoresis. The purified protein was concentrated to ~ 200 μM, 
divided into 100 μL aliquots, and stored in 50% glycerol at -80 °C.  
Sample Preparation   
Small aliquots of iNOSoxy were thawed and exchanged into phosphate buffer (50 
mM KPi, 50 mM KCl, pH 7.4) using a PD-10 desalting column (BioRad) immediately 
before use. The position of the heme Soret maximum (422 nm) confirmed the presence of 
low-spin, water-bound heme.17, 32 The heme protein concentration was determined using 
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ε422 = 75 mM-1cm-1 per unit heme.17 For the inhibitor-bound samples, imidazole (400-500 
μM) was added, and binding was confirmed by a Soret shift to 428 nm.17, 32 For substrate-
bound, pterin-free samples, 1 mM arginine was added to dilute (~ 2–20 μM) iNOSoxy 
and allowed to incubate at 4 °C for approximately 30 min. In the absence of pterin (BH4), 
only partial conversion to a high-spin heme (λmax = 398 nm 32-33) was observed. For 
substrate- and pterin-bound samples, fresh BH4 solutions were prepared daily. Phosphate 
buffer was thoroughly deoxygenated by bubbling with argon for ≥ 10 min. Solid BH4 was 
added to the degassed buffer under a counter-flow of argon. Dilute iNOSoxy (~ 2–20 
μM) was deoxygenated by at least 30 evacuation-Ar backfill cycles, taking care to avoid 
bubbling of the solution. Aliquots of concentrated, deoxygenated pterin and arginine 
stocks were then added to the protein solution, giving final concentrations of 100 μM 
BH4 and 1 mM arginine. The solution was incubated for 2 h at 4 °C; binding of BH4 and 
arginine was confirmed by a Soret shift to 396 nm.34-35  
 For quenching experiments, 1 M ascorbate stock solutions were prepared daily by 
dissolving ascorbate in thoroughly deoxygenated 1 M KOH. Ascorbate (1 M) and solid 
TMPD were added to deoxygenated protein solutions under a counter-flow of argon.  
Transient Spectroscopy   
Luminescence decay and transient absorption measurements were made as 
described previously.7, 36-37 The ~ 8 ns, 480 nm excitation pulses were produced by a 
Nd:YAG pumped optical parametric oscillator. Data were collected at 1×109 samples s-1 
using a LeCroy digital oscilloscope. Transient absorbance data were converted from 
intensity to absorbance using the following expression (Eq. 2.3): 







IAbs    (2.3) 
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where I is the intensity of light transmitted through the sample excitation volume, and I0 
is the average transmitted light intensity during the 200 ns prior to the laser shot. 
Luminescence decay curves and transient absorbance traces were fit to one, two, or three 
exponentials using a nonlinear least-squares algorithm (Eq. 2.4, Igor Pro): 




necctI 0)(    (2.4) 
Each experiment was repeated at least three times unless indicated otherwise.  
Determination of RuI→FeIII ET Rate Constants   
At a given time after excitation, the absorbance observed at a given wavelength 
(λ) between 400 and 450 nm is (Eq. 2.5): 
        IRuRuIIRuRuIIFeFe RuRuFeAbs IIIIIIIIIIII  **  (2.5) 
Since ascorbate, TMPD, and TMPD+• do not absorb strongly in this region (under the 
conditions of these experiments, Figure 2.9), the contributions of these species were 
neglected. Owing to substantial populations of unbound Ru-complex, the absorbance 
changes at these wavelengths due to depopulation of RuII and formation of *RuII are large 
compared to those for FeII formation because [*RuII]>>[FeII]. Moreover, the presence of 
both free and iNOSoxy-bound wire complicates the transient absorbance kinetics. In 
fitting these data, we were unable to identify a phase that was distinct from those 
corresponding to *RuII decay in bound and free wires, and that reliably could be 
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reductants to produce FeII.6 In this experiment, a quencher (Q) reduces the photoexcited 
sensitizer to create a strongly reducing species (RuI in Scheme 2.5). In the absence of 
other electron acceptors, the lifetime of RuI is dependent on the rate of recombination 
with the oxidized quencher (kr in Scheme 2.5). Because Q+ and RuI are present at low 
and equal concentrations, recombination is slow (ms timescale) and heme reduction 
competes effectively.  
 
Scheme 2.5. Representation of the reversible flash/quench experiment employed in this 
work. For simplicity, TMPD and ascorbate are represented together as Q. In a successful 
flash/quench experiment, quenching must compete with intrinsic relaxation (k0) and 
energy transfer (ken) for depletion of the RuII excited state (kQ[Q] ≥ k0 + ken); and electron 
transfer (kET) must be faster than recombination between oxidized quencher and reduced 
sensitizer (t½ = 1/kr[RuI]0).  
 
Owing to its high solubility in water and lack of spectral interference with heme 
Soret changes, ascorbate (Asc) is an attractive choice as a quencher for this system. Even 
at high concentrations (10 mM), however, Asc quenching produces only small yields of 
FeII (Figures 2.12 and 2.13). TMPD (Scheme 2.6) is a better quencher than Asc, but has 
limited solubility in water.39-40 Further, TMPD autoxidizes to create a soluble bright blue 
cation radical in aqueous media.41 Under conditions necessary for efficient excited-state 
quenching, the production of the radical rapidly turns the solution dark blue, obscuring 
small transient changes in the heme spectrum. 
Q + Ru(II)* --- Fe(III)
Q + Ru(II) --- Fe(III)
Q+ + Ru(I) --- Fe(III)
Q+ + Ru(II) --- Fe(II)
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This is a remarkably rapid reduction given the estimated Ru-heme distance of 
20.2 Å17 and the absence of a through-bond pathway to the heme. Given its slim profile, 
hydrophobicity, and potential to π-stack with aromatic residues, the perfluorobiphenyl 
moiety of tmRu-F9bp may intercalate into the protein interior, leaving open the 
possibility of a through-wire hopping mechanism.28 
Identity of the Reduced Species   
In order to determine the nature of the product of electron transfer to the heme, 
the six-coordinate FeIII-Im species was reduced under equilibrium conditions for 
comparison with the transient data. Reaction of FeIII-Im with sodium dithionite in a glove 
box under an inert atmosphere, followed by removal of excess dithionite on a size-
exclusion (PD-10) column equilibrated with 10 mM imidazole, produced a species with 
the absorption spectrum shown in Figure 2.18. 
Reduction of NOS has been extensively studied.25, 35, 44-47  Six-coordinate ferrous-
NO and -CO species have been characterized by several investigators;35, 46-47 and, in the 
absence of arginine and BH4, it has been shown that these six-coordinate species are 
unstable. Addition of CO (or NO) to five-coordinate FeII causes a red-shift in the Soret 
band to 444 nm (or 440 nm).35  The 444 nm band blue-shifts over time to 421 nm, which 
suggests that a species analogous to the inactive P420 form of cytochrome P450 is 
produced. It has been proposed that the axial thiolate is not bound to the heme iron in the 
421 nm species35, 47 of that the thiolate is protonated.48  
The blue-shift of the iNOSoxy Soret peak upon dithionite reduction (Figure 2.18, 
inset) demonstrates that the red-shifted transient FeII species produced by photochemical 
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product that is observed under equilibrium conditions. We suggest that the transient FeII 
iNOS species formed by photochemical reduction contains a low-spin FeII heme with 
axial Cys and imidazole ligands. In our experiment, this species is likely reoxidized by 
TMPD+• before loss of axial ligation, which would generate the species observed under 
equilibrium conditions.   
 
2.5 Concluding Remarks and Discussion 
 We have developed a system in which the heme of inducible nitric oxide synthase 
can be photoreduced rapidly without interfering with substrate/cofactor binding. 
Employing flash/quench experiments with a surface-binding Ru-diimine wire in 
combination with reductive quenchers, we observed ET to the imidazole-bound heme of 
iNOSoxy fully seven orders of magnitude faster than the natural reduction. This finding 
represents an important step toward our goal of identifying reactive intermediates in the 
catalytic cycles of heme monooxygenases.  
 Interestingly, however, the product of this ET reaction is a six-coordinate heme. 
In contrast, the product of steady-state reduction of the heme is consistant with either a 
five-coordinate species with imidazole ligation or a complex where the negative axial 
thiolate ligand becomes protonated forming a neutral thiol ligand.  On the millisecond 
timescale this six-coordinate species is stable, however, over the long term it will decay 
to the more thermodynamically favored five-coordinate or neutral thiol complex. This 
decay highlights the inherent instability of the thiolate-ligated heme complex.  
 Upon closer inspection of the environment around the thiolate ligand, one finds a 
collection of three hydrogen bond (H-bond) donors all directed toward the thiolate. 
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Comparison of iNOSoxy with other NOS enzymes reveals that these three hydrogen bond 
donors are universally conserved, with not a single exception. This high level of 
conservation underscores their potential importance. Not only are they conserved in nitric 
oxide synthases, but the crystal structures of other heme thiolate enzymes reveal similarly 
conserved hydrogen bond donors in all. Cytochrome P450s (cyt. P450) all contain three 
H-bond donors; chloroperoxidase (CPO) contains only two such donors.  
When analyzing these polypeptide chains, one finds that in cyt. P450 and CPO all 
three donors in the proximal heme environment come not from amino acid side-chains 
but from amide protons in the backbone of the polypeptide chain. In NOS alone one and 
only one of the H-bond donors comes not from an amide but from the N-H of a 
tryptophan’s indole ring, Figure 2.19. The universality of these H-bond donors pointing 
right at the axial thiolate ligand provokes questions of their function in the reactivity or 
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donor decreases the σ-donating ability of the thiolate significantly; its removal 
strengthens the iron-sulfur bond. They “conclude that the functions of the proximal 
hydrogen bonding network in P450cam are to stabilize the heme-thiolate coordination, and 
to regulate the redox potential of the heme iron.”54 While these conclusions seem 
reasonable, it is difficult to say the effect of a particular H-bond when several things are 
affected at once.  
We wish to determine the role of these H-bond donors and support or refute the 
previous findings, but particularly to study their effects in NOS. This family of enzymes 
provides a unique opportunity, given that one of the H-bond donors comes not from the 
backbone but from a side chain, allowing for facile and systematic variation using site-
directed mutagenesis. Several such mutations have previously been made in NOS and 
characterized by resonance Raman.55-56 No further characterization has been reported.  
One other mutant of interest replaced the tryptophan with a histidine, preserving 
and possibly increasing the H-bond donor ability of the group. In this mutant, researchers 
actually saw a slower kinetics profile and possibly a new intermediate by stopped-flow 
spectroscopy.25 No further characterization was done and the new intermediate, based 
solely upon the position of the Soret band, was suggested to be Compound I (Scheme 
2.3, the ferryl complex in blue).  The lifetime of this new intermediate is on the order of a 
couple of seconds before decaying to product. Compound I is formally a Fe(V) complex, 
with a ferryl and another radical cation sometimes found on the porphyrin ring. The 
likelihood of such a species living for that length of time is incredibly low as it will be 
very reactive, making its assignment as Compound I doubtful.14 No other investigations 
into the role of this H-bond donor have been made.  
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We propose to investigate the role of these H-bond donors by systematically 
varying the functional groups on this side chain in question through the use of site-
directed mutagenesis. The native tryptophan will be replaced with histidine, 
phenylalanine, or tyrosine. Histidine can also participate in hydrogen bonding, but lacks 
the ability to π-stack with the porphyrin ring. Phenylalanine complements the histidine 
mutation in that it can π-stack but cannot hydrogen bond. The tyrosine can also π-stack, 
but the electronics should be significantly altered due to the presence of the hydroxyl 
group on the aryl ring, which is at an angle that should prohibit hydrogen bonding with 
the thiolate. These three mutants will be expressed and thoroughly characterized using 
the tools of modern bioinorganic chemistry to investigate the thermodynamics of the 
resulting active site and its reactivity (EPR, electrochemistry, single turnover 
experiments, etc.). These studies should provide valuable insight into the specific role of 
these hydrogen bond donors and their purpose in NOS and other heme thiolate enzymes, 
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 All heme thiolate enzymes have conserved hydrogen bonding networks 
surrounding the axial thiolate ligand. In order to understand the role of this proximal 
hydrogen bonding network in nitric oxide synthases, three mutants of the NOS enzyme 
from Geobacillus stearothermophilus were expressed and characterized. The wild type 
enzyme has a tryptophan residue at position 70 that π-stacks with the porphyrin ring and 
donates a long hydrogen-bonding interaction to the thiolate ligand of the heme iron. The 
native Trp was replaced with His, Phe, and Tyr. These three residues were selected to 
investigate the two effects of the Trp, H-bonding and π-stacking. Several different 
spectroscopic techniques were used to investigate the stability and properties of these 
mutant enzymes. The identity of each mutant was confirmed by mass spectrometry. Both 
UV-visible absorption and circular dichroism spectroscopies were used to assess the 
stability of the new proteins. It was shown using binding assays, generation of the 
ferrous-CO species, and redox titrations that the σ-donating abilities of the thiolate are 
increased after removal of the hydrogen bonding group in the Trp. Finally, electron 
paramagnetic resonance spectroscopy and Evans method nuclear magnetic resonance 
spectroscopy were used to characterize the spin state of the iron center in each mutant, 
reflecting the increased σ-donating capabilities of the thiolate upon removal of the 
hydrogen bonding group. The reduction potential of wild type and W70H were 
determined by chemical titration to be -362 and -339 mV vs. NHE, respectively. This is 






 Heme-thiolate enzymes play important roles in human physiology such as drug 
metathesis and in the production of signaling molecules involved in processes such as 
neurotransmission.1-2 Cytochromes P450 (cyt. P450) are a super-family of these 
interesting heme enzymes and many different forms are found in mammals.3 They carry 
out a broad array of biological transformations from epoxidation of alkenes to 
isomerizations and many different oxidation and reduction reactions. They are most 
famous for their ability to hydroxylate unactivated carbon-hydrogen bonds. It would take 
a unique and highly reactive complex to afford such difficult and varied reactions.  
 There are only a small number of heme-thiolate enzymes (counting cyt. P450 as a 
single entity).3 Joining cyt. P450 are the nitric oxide synthases (NOS) and 
chloroperoxidase (CPO). CPO carries out the typical peroxidase and catalase activities of 
any standard peroxidase enzyme.4 It is unique among peroxidases, however, in its ability 
to use hydrogen peroxide to oxidize the halogens iodide, bromide, and chloride, and use 
them to form carbon-halogen bonds on substrates.  
   The family of enzymes called nitric oxide synthases (NOSs) is responsible for 
biological production of NO.5 This family includes three isoforms named for the tissues 
in which they are found: endothelial NOS (eNOS), neuronal (nNOS), and an inducible 
form found in macrophages (iNOS).  The function of eNOS and nNOS is regulated by 
calcium ions and a calmodulin linker, while the inducible isoform is calcium ion 
independent.6  NOSs catalyze the oxidation of L-arginine (Arg) to L-citrulline in two 
turnovers, with Nω-hydroxy-L-arginine (NOHA) as an intermediate (the product of the 
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(characteristic absorbance of metalloporphyrins, 421 nm for substrate- and pterin-free 
iNOS)17 as well as the spin-state (from low- to high-spin ferric).18 The Soret of pterin- 
and arginine-loaded iNOS occurs at 390 nm.  This is followed by a one-electron 
reduction of the iron to ferrous. Ferrous heme readily binds oxygen, forming a ferrous-
oxy species (equivalent to ferric-superoxide),8 the last observed intermediate in the 
catalytic cycle.8, 19   
The role pterin has been extensively investigated.11, 16, 20 This molecule binds in a 
pocket alongside the heme, forming hydrogen bonds with a carboxylate group on the 
heme directly coupling it to the iron active site.13 It is known that a pterin-based radical 
forms and is reduced during the cycle (Scheme 3.2), as determined by rapid-freeze 
electron paramagnetic resonance experiments.12, 21 The current hypothesis is that proton-
coupled electron transfer from pterin aids in formation of the hydroxylating species.10, 20 
No turnover has ever been observed without the pterin cofactor bound.22 The pterin 
cofactor is thought to be essential for producing the active hydroxylating species through 
proton-coupled electron transfer. The efforts of this study focus on characterizing the iron 
active site. 
The known mechanistic data and overall reaction bear many similarities to 
cytochrome P450s (CYP450).  The CYP450s contain cysteine-ligated hemes and 
hydroxylate their substrates via a two-electron oxidation.23-24  Their mechanism also 
begins with substrate binding and is followed by reduction, dioxygen binding, and 
another reduction step leading to the formation of high-valent iron-oxo species which are 
very reactive and hydroxylate the nearby substrate.24  Separate enzymes serve as 
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oxide synthases is too fast to catch all of the intermediate steps. Using this technique, the 
final observable species before product formation is the ferrous-oxy (or ferric-superoxo 
depending on formal placement of the electron).6 In the first turnover, the next species 
observed is the resting ferric state and in the second turnover it is the ferric-NO complex, 
which slowly releases NO to finish the cycle. No other intermediates can be seen by 
stopped-flow, presumably due to the speed with which they react.  
Evidence supporting that the hydroperoxo species (in blue) is the active oxidant in 
the second turnover comes mainly from the ENDOR (electron-nuclear double resonance 
spectroscopy) studies conducted on the NOS from Geobacillus stearothermophilus 
(gsNOS) by Brian Hoffman and Roman Davydov.28-29 These experiments show cleavage 
of the O-O bond prior to reaction with substrate in the first turnover, supporting the 
formation of Compound I or a similar species. In the second turnover, however, no 
cleavage of the O-O bond is observed prior to attack on substrate. They hypothesize that 
the presence of the hydroxyl group in NOHA makes the substrate easier to oxidize. The 
hydroperoxo heme complex might have enough oxidizing power to react with NOHA but 
not the arginine, requiring Compound I in the first turnover.  
 It is the O-O bond cleavage event that is vital to the reactivity of NOS and cyt. 
P450. Without this, Compound I cannot form and the active site will fail to produce a 
species with sufficient oxidizing power to react with substrates such as unactivated 
alkanes. It has been hypothesized that the role of the thiolate ligand is to promote this 
cleavage.30 The strong σ-donating ability of the anionic ligand pushes more electron 
density into the iron and therefore also into the iron-oxygen bond and weakening the O-O 
bond. This has been dubbed the “thiolate push”.31 
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 Upon closer inspection of the environment around the thiolate ligand, one finds a 
collection of three hydrogen bond (H-bond) donors all directed toward the thiolate. 
Comparison of gsNOS with other NOS enzymes reveals that these three hydrogen bond 
donors are universally conserved, with not a single exception.32 This high level of 
conservation underscores their potential importance. Not only are they conserved in nitric 
oxide synthases, but the crystal structures of other heme thiolate enzymes reveal similarly 
conserved hydrogen bond donors in all. Cytochrome P450s (cyt. P450) all contain three 
H-bond donors; chloroperoxidase (CPO) contains only two such donors.3 
When analyzing these polypeptide chains, one finds that in cyt. P450 and CPO all 
three donors in the proximal heme environment come not from amino acid side-chains 
but from amide protons in the backbone of the polypeptide chain. In NOS alone one and 
only one of the H-bond donors comes not from an amide but from the N-H of a 
tryptophan’s indole ring, Figure 3.1. The universality of these H-bond donors pointing 
right at the axial thiolate ligand provokes questions of their function in the reactivity or 
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donor decreases the σ-donating ability of the thiolate significantly; its removal 
strengthens the iron-sulfur bond.33 They “conclude that the functions of the proximal 
hydrogen bonding network in P450cam are to stabilize the heme-thiolate coordination, and 
to regulate the redox potential of the heme iron”.35 While these conclusions seem 
reasonable, it is difficult to say the effect of a particular H-bond when several things are 
affected at once.  
We wish to determine the role of these H-bond donors and support or refute the 
previous findings,36 but particularly to study their effects in NOS. This family of enzymes 
provides a unique opportunity, given that one of the H-bond donors comes not from the 
backbone but from a side chain, allowing for facile and systematic variation using site-
directed mutagenesis. Several such mutations have previously been made in NOS and 
characterized by resonance Raman.37-38 These studies show that removal of this H-bond 
donor strengthens the Fe-S bond. No further characterization has been reported.  
One other mutant of interest replaced the tryptophan with a histidine, preserving 
and possibly increasing the H-bond donating ability of the group. In this mutant, 
researchers actually saw a slower kinetics profile and possibly a new intermediate by 
stopped-flow spectroscopy.39 No further characterization was reported, and this new 
intermediate was suggested to be Compound I, based solely upon the position of the 
Soret band (Scheme 3.2, the ferryl complex in blue).  The lifetime of this new 
intermediate is on the order of a couple seconds before decaying to product. Compound I 
is formally a Fe(V) complex, with a ferryl and another radical cation sometimes found on 
the porphyrin ring. The likelihood of such a species living for that length of time is 
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incredibly low as it will be very reactive, making its assignment as Compound I 
doubtful.40 No other investigations into the role of this H-bond donor have been made.  
We investigated the role of these H-bond donors by systematically varying the 
functional groups on this side chain in question through the use of site-directed 
mutagenesis. The native tryptophan was replaced with histidine, phenylalanine, or 
tyrosine. Histidine can also participate in hydrogen bonding, but lacks the ability to π-
stack with the porphyrin ring. Phenylalanine complements the histidine mutation in that it 
can π-stack but cannot hydrogen bond. The tyrosine can also π-stack, but the electronics 
should be significantly altered due to the presence of the hydroxyl group on the aryl ring, 
which is at an angle that should prohibit hydrogen bonding with the thiolate. These three 
mutants have been expressed and thoroughly characterized using the tools of modern 
bioinorganic chemistry to investigate the thermodynamics of the resulting active site 
(EPR, electrochemistry, etc.). These studies provide valuable insight into the specific role 
of these hydrogen bond donors and their purpose in NOS and other heme thiolate 
enzymes. 
 All studies were conducted using the nitric oxide synthase from the thermophilic 
bacterium Geobacillus stearothermophilus. This particular organism spends its entire 
existence at elevated temperatures, forcing the optimization of the function of its 
enzymes to this elevated temperature range (a thermal melting curve for the wild type 
enzyme gsNOS is shown in Figure 3.2). Due to this, the NOS from G. bacillus (gsNOS) 
functions optimally at temperatures well above other NOSs and shows a remarkably 
slowed kinetics profile at standard laboratory temperatures (such as 4 and 10 °C). 
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 The wild type enzyme has a tryptophan residue at position 70 which hydrogen 
bonds with the thiolate ligand and π-stacks with the porphyrin ring of the heme. This Trp 
was replaced systematically by His, Tyr, and Phe. The wild type and these three mutant 
enzymes were studied by several techniques to characterize the thermodynamics of the 
active site. It was found that while these mutations do not greatly alter the stability of the 
protein or its overall fold, they do tune the electronics of the active site, shifting the spin 
state and altering the potential of the site.  
 
3.3 Materials and Methods 
General 
 The plasmid for the nitric oxide synthase from Geobacillus stearothermophilus 
was a gift from the lab of Brian Crane. This enzyme was expressed as previously 
described by Sudhamsu and Crane with no significant deviations in procedure.41 The 
enzyme was overexpressed in Escherichia coli BL21 (DE3) cells. Cells were grown to an 
optical density of approximately 1.0–1.4 and induced by adding a solution containing 
iron(III) chloride, IPTG, and δ-aminolevulinic acid (Aldrich) to final concentrations of 
125 mg/L, 100 µM, and 50 mg/L, respectively, in milliQ water. The pETDuet vector 
(Novagen) coded for a C-terminal cleavable His6-tag so samples were purified using 
metal affinity chromatography. (This vector also confers chloramphenicol resistance to 
the cells, so 34 µg/mL of this antibiotic were added to all cultures in Luria broth.) The 
His6-tag was then cleaved using bovine thrombin (Calbiochem). Both thrombin and the 
His-tag were removed using size exclusion chromatography. Sample purity and Soret 
band epsilon values were determined through use of the Hemochromagen Assay.  
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 A QuikChange site-directed mutagenesis kit from Stratagene was used to make 
the desired mutations in the amino acid chain. Primers were designed according to the 
guidelines outlined by the QuikChange kit manual. Unless otherwise noted, protein 
solutions were made in the following buffer: 50 mM Tris (2-amino-2-hydroxymethyl-
propane-1,3-diol), 150 mM NaCl, pH 7.5 (the same buffer used for size exclusion 
chromatography).  
Circular Dichroism Spectroscopy 
 Circular dichroism spectroscopy was used to determine the stability of each 
protein sample. Chiral objects interact with circularly polarized light in such a way as to 
turn or distort the polarization of the light.43 This is measured as ellipticity. Chiral 
features in macromolecules such as alpha helices or beta sheets are associated with 
particular signals by circular dichroism. Due to the size of the protein samples in question 
(gsNOS contains 375 residues with significant contributions from both alpha helices and 
beta sheets) the concentration of NOS in each cuvette was kept below 2 µM. Samples 
with greater concentrations gave signals too large for the spectrometer to resolve. Alpha 
helices give characteristic ellipticity at 222 nm, to the red of the part of the spectrum 
where buffer would begin to affect the signal. For this reason, the standard Tris buffer 
was still used for these measurements. Spectra were collected scanning from 210 nm to 
260 nm, stepping every one nm, to record the elliptical properties of the enzyme sample. 
In all cases the mximum signal was observed between 220 and 225 nm. To record the 
effects of temperature on each sample, the detector was fixed at 222 nm and the 




UV-Visible Absorption Spectroscopy  
UV-visible absorption spectroscopy is a particularly useful technique for 
characterizing heme proteins, as the position and shape of the Soret absorption band of 
the heme center is extremely sensitive to both the oxidation state of the iron and the 
coordination sphere around that iron. The maximum absorption of the Soret band can 
shift tens of Ångstroms due to simple additions of coordinating molecules such as 
imidazole or carbon monoxide.44 UV-visible absorption spectra were acquired on an 
Agilent 8453 UV-visible spectrophotometer with a 2 nm resolution. 
A common method for characterizing heme-thiolate enzymes and assessing their 
stability is by forming the ferrous-CO complex.37 It is the strong, sharp absorption of this 
band at 450 nm that gives cytochrome P450 its name. The Soret band of ferrous-CO NOS 
typically lies to the blue of cyt. P450 at 446 nm. Samples were brought into an anaerobic 
glove box and reduced using dithionite. Excess dithionite was then removed using a PD-
10 desalting column (although removal is not necessary in all situations). The samples are 
then sealed by Köntes valve in a quartz cuvette and brought out of the box. The 
headspace of this special cuvette was then connected to a tank of carbon monoxide and 
this gas was bubbled over the headspace, replacing the atmosphere. As CO diffuses into 
solution, the ferrous-CO complex is rapidly formed. The cuvette was then re-sealed and 
UV-vis spectra collected.      
Hemochromagen Assay 
 The heme center with its Soret absorption band provides a particularly useful 
handle for determining protein concentration as well. The Hemochromagen Assay allows 
researchers to characterize the molar absorptivities of heme centers in protein samples to 
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a degree that is far more accurate than the standard Bradford Assay.45 In this method, the 
protein is denatured using strong base to liberate the heme center and pyridine is added in 
large excess to force coordination of the heme. This five-coordinate pyridine-heme is 
then reduced with dithionite to yield a ferrous complex (called a hemochrome) with a 
known and distinct absorption in the Q-band region. This new complex has two sharp Q-
bands, the lower energy of which has a larger molar absorptivity of 34,640 M-1cm-1.45 As 
long as the original spectrum of the fully-oxidized resting state of the enzyme is recorded 
first, the hemochrome can then be generated and the concentration of the sample can be 
calculated based on heme concentration using the known epsilon value of the 
hemochrome.  
 Samples of wild type gsNOS and all three mutants were made with absorbances 
between 0.3 and 1.0 (to keep the % transmittance within the best working range of the 
spectrophotometer. Each sample was prepared in a specialized cuvette (Figure 3.4), 
allowing the sealing of the sample from atmosphere, or its connection to a Schlenk line, 
all while in a quartz cuvette allowing for measurement of the UV-visible absorption 
spectrum. A spectrum of each protein sample was collected initially, before any additions 
or degassing; each sample was exactly 1 mL of approximately 4–10 µM enzyme. Then 
125 µL of each pyridine and 1 M NaOH were added to the sample. The spectrum was 
again recorded to verify denaturation of the protein. Samples then had to be very 
thoroughly degassed through at least 30 rounds of gentle pump/purge to remove oxygen 
from the atmosphere and allow equilibration of the argon atmosphere with solution. 
Several crystals of solid dithionite were placed in the bulb, while the sample was kept 
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Binding Assays  
 The interaction of substrates with the active site can be characterized 
spectroscopically using UV-visible absorption spectroscopy. With heme proteins, the 
introduction of substrates or inhibitors to the binding pocket often shifts the position and 
shape of the Soret band in a characteristic manner.46 Here, the substrate is arginine and 
the inhibitor is imidazole. The relationship between the concentration of 
substrate/inhibitor added and the resulting spectral shift has been calculated as follows in 






௄ೞ      (3.1) 
where ΔOD is the change in absorbance due to the presence of the substrate or inhibitor 
and m is the slope of the resulting line, [imid] is the concentration of analyte added (in 
this case, imidazole).47 This simple linear relationship allows for the calculation of a 
dissociation constant, KS, through facile spectroscopic characterization by UV-vis (the 
symbol KS is used to distinguish this term as a spectral dissociation constant rather than a 
traditional dissociation constant, KD. This technique requires a large shift in absorbance 
to give reliable results. In some cases, a competition assay was required in order to see 
significant shifts in the Soret band (the protein was pre-loaded with imidazole of a known 
concentration and then arginine was added to that sample to displace the imidazole).  
Electron Paramagnetic Resonance Spectroscopy (EPR) 
 One unique feature of heme-thiolate systems is related to the spin state of the iron. 
The electronics of these systems is poised just so that the pairing energy (the energetic 
cost of placing two electrons in the same orbital due to their mutual repulsion) and 
ΔOctahedral (the splitting between the Eg and T2g states of the metal center) are nearly 
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identical. Under different conditions both high spin and low spin states can be observed, 
and often a mixture of the two states is seen. With Fe(III), high spin complexes have a 
spin of S = 5/2 and low spin complexes have a spin of S = 1/2.   
 EPR requires the glassing of frozen samples and the random alignment of all 
paramagnetic species. In order to ensure glass formation, high glycerol concentrations are 
used. Samples were prepared with the following conditions: 20 µM NOS, 20% by 
volume glycerol, 50 mM NaCl, 50 mM Tris at pH 7.5. Samples containing arginine had 
an Arg concentration of 300 µM in order to ensure full formation of the arginine-bound 
complex, and all were pre-frozen by rapid immersion in liquid nitrogen. Spectra were 
collected using a Bruker EMX Biospin instrument with a Gunn diode microwave source. 
Liquid helium was used to cool the instrument and sample and spectra were collected at 
20 K. EPR parameters were simulated using the software package SPINCOUNT.48  
Evans Method NMR 
 To determine the spin state of samples at room temperature, Evans method 
nuclear magnetic resonance spectroscopy (NMR) was applied. With this method, one can 
determine the spin state of a sample by the paramagnet’s affect on the surrounding 
solvent.49 Samples were prepared with 1 mM protein sample inside of a capillary-like 
insert (Wilmad, part number WGS-5BL). These inserts are designed to fit inside of a 
standard NMR tube, with buffer in the surrounding space. This allowed the use of less 
than 100 µL of protein sample, reducing the total amount of protein required. The 
presence of the paramagnetic iron center in the protein shifts the NMR peak of the water 
in the buffer. The magnitude of this shift is directly related to the concentration of the 
paramagnet and the number of unpaired electrons in that species (Equations 3.2, 3.3, and 
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3.4, specifically for a 600 MHz NMR spectrometer, from the manual for Chemistry 3b at 
Caltech). Samples were prepared with the standard buffer (50 mM Tris, 150 mM NaCl, 
pH 7.5) but with 20% D2O and 80% H2O rather than 100% H2O as an internal standard to 
allow for proper tuning of the magnet.   




௠ቁ ൅	ܺ଴                               (3.2) 
In the above equation, Xg is the gram susceptibility of the sample, ν is the measured 
frequency of the NMR signal, m is the mass of the paramagnetic material in 1 mL of 
solution, and X0 is the gram susceptibility of the pure solvent (water being -7.203 × 10-7 
cm3g-1). This gram susceptibility is then used in Equation 3.3 to determine the number of 
unpaired electrons in the paramagnetic sample.  
ܺெ ൌ 	 ௚ܺܯ                       (3.3) 
ߤ ൌ 	2.84ඥܺெܶ ൌ 	ඥ݊ሺ݊ ൅ 2ሻ     (3.4) 
XM is the molar susceptibility of the sample in question, M is its molecular weight, and T 
is the temperature in Kelvin. These equations allow one to calculate the number of 
unpaired electrons in a given system as long as the two solvent peaks (with and without 
the paramagnetic species) can be resolved.   
Redox Titrations 
 In order to measure the reduction potential of each protein sample, redox titrations 
were carried out. In this technique, a chemical oxidant or reductant is added to the protein 
sample. This chemical reactant should have a reduction potential close to that of the 
protein being studied (± 100 mV) in order to observe equilibrium between oxidized and 
reduced forms from sub-stoichiometric reaction with the protein sample. The reduction 
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potential of other NOSs has been measured previously and found to typically lie in the 
range of -250 to -300 mV vs. NHE.16, 39 Ru3+(acac)3 was chosen as a chemical oxidant 
because it has a reversible reduction potential at -275 mV. The protein was reduced under 
inert atmosphere in a glove bag (experiments were carried out in the lab of Michael 
Marletta at UC Berkeley) and sealed in a cuvette along with the Ru(acac)3 sample (in the 
syringe) of a specialized apparatus for this reaction shown in Figure 3.5. Small aliquots 
of ruthenium complex were added at a time, the sample was mixed and the resulting 
spectrum collected. This technique relies on the absorption of the oxidized and reduced 
species of one of the two reactants to be well resolved. From the UV-vis spectrum, the 
concentrations of the oxidized and reduced form of each of the two reactants can be 
calculated given the molar absorptivities and the Nernst Equation applied to give the 
reduction potential of the protein.  
∆ܩ ൌ 	െ݊ܨܧ ൌ 	െܴ݈ܶ݊ܭ௘௤     (3.5) 
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 The thermal denaturation data collected show a somewhat remarkable result: none 
of the mutant enzymes shows a marked decrease in stability toward temperature. Given 
the two roles of this residue at position 70, it was hypothesized that these roles were vital 
to the fold of the protein. The fact that all four enzymes are stable to 60 °C and show 
similar behavior to the wild type above that temperature proves this hypothesis to be 
false. The His mutant (shown in yellow in Figure 3.6) may begin to unfold at slightly 
lower temperatures than wild type, consistent with the π-stacking of the Trp being 
important for positioning the heme in the enzyme. However, this effect is very small. The 
Tyr and Phe mutants, if anything, show increased stability over the wild type. Again, this 
is consistent with the hypothesis, as these two residues preserve the π-stacking function. 
They cannot provide a hydrogen bond to the thiolate (the hydroxyl group of the tyrosine 
side chain is pointed at an unfavorable angle, away from the thiolate), but the data show 
that this does not destabilize the enzyme.  
 Another common method for determining the stability of heme-thiolate enzymes 
involves the generation of the ferrous-CO complex. It is this form of the enzyme that 
absorbs strongly near 450 nm, giving cytochromes P450 their name. This tests 
specifically the stability of the heme center and the iron-thiolate bond. Cyt. P450s and 
NOSs are known to form an inactive form called P420 under some conditions.52 This has 
been proposed to be either loss of axial thiolate coordination or protonation of the axial 
thiolate to make a neutral thiol ligand. In the case of NOS, it has even been shown to be 
reversible inactivation of the enzyme, but without the proper thiolate ligation the enzyme 


















































 Upon formation of the ferrous-CO complex, the wild type gsNOS shows stable 
formation of the six-coordinate complex with maximum absorption at 446 nm as 
expected (Figure 3.7). The W70H mutant also shows stable formation of this complex, 
however with a blue-shifted Soret band at 440 nm. The reason for this blue shift is 
unknown, but may arise from altered tuning of the porphyrin ring. The two remaining 
mutant enzymes, W70Y and W70F, both remove hydrogen bonding capabilities. Over the 
course of 24 hours, both mutants show near complete formation of the P420 species 
(Figure 3.8). Removal of this one H-bond donor may increase interactions with the other 
two donors and increase the σ-donating ability of the thiolate ligand to the iron center. 
The data suggest that this third, distant (3.7 Å) H-bond donor stabilizes the enzyme in the 
active form by either decreasing the thiolate ligand’s σ-donating ability or by preventing 
any one H-bond from being too strong in order to reduce the risk of protonation of the 
thiolate, or some combination thereof.  
 In the catalytic cycle of NOS, a similar ferrous-O2 complex must form and remain 
stable on the timescale of catalysis in order for the enzyme to productively form NO. The 
electron density on the iron must be tuned in order to stabilize that six-coordinate species, 
yet still allow for ligand dissociation from the ferric-NO species formed in the last step of 
catalysis (Scheme 3.2). This unique requirement, the release of NO, may be the reason 
for the differences between the NOS and cyt. P450 proximal H-bonding network. In cyt. 
P450 all three H-bonds come from the amide backbone, while only two come from the 
backbone in NOS, the third coming from this Trp residue. Cyt. P450 has a separate 
phenylalanine residue for π-stacking with the porphyin ring, rather than combining these 
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Table 3.1. Spectral dissociation 
constants of imidazole and arginine. 
 (µM)  Ks (arg) Ks (imid) 
WT 4.0 38 
W70H  4.5 88 
W70F  3.2 130 
W70Y  4.3 210 
 
It is clear from the values in Table 3.1 that while the interaction of imidazole with 
the heme is greatly affected by mutations at position 70, the dissociation constant of 
arginine remains unaffected. This can be explained by the manner in which each 
substance binds. Arginine is positioned in the binding pocket above the heme, without 
directly ligating the iron. It is held in place by hydrogen bonds and hydrophobic contacts 
within the substrate channel.13, 53 A high spin five-coordinate complex is formed; arginine 
merely kicks out the water molecule that weakly coordinates the iron. Imidazole, on the 
other hand, directly coordinates the iron, forming a bond between the iron and nitrogen of 
the ring. As the hydrogen bond donating group is removed, the thiolate becomes a better 
donor to the iron. This increases the electron density on the iron. The direct ligation of the 
imidazole forces even more electron density into the iron, which is disfavored, so as the 
thiolate becomes a better donor, the imidazole binds less tightly.  
UV-Visible Characterization of the Resting State 
 As stated previously, electronic absorption spectroscopy is a useful tool for 
characterizing heme enzymes. The Hemochromagen Assay is used to determine protein 
concentration based on heme concentration. This assumes the presence of one heme unit 
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paramagnetic spin state. NMR experiments can be carried out at room temperature, 
allowing for a more direct comparison with UV-vis. The presence of paramagnetic 
compounds in high concentrations shifts the resonance of the solvent peak. This shift is 
related to the number of unpaired electrons in the complex by the Equations 3.2, 3.3, and 
3.4. Table 3.4 shows results of these measurements. Strengthening the H-bonding 
capabilities of the residue at position 70 decreases the number of unpaired electrons 
relative to wild type, while removing that H-bond increases the number of unpaired 
electrons and shifts the sample further towards high spin. These results agree with those 
from UV-vis and together confirm that the enzyme is predominantly high spin in 
character at room temperature (low spin would have one unpaired electron, high spin 
would have five).  
Table 3.4. Unpaired electrons for each mutant as determined by Evans method.  
Sample  delta, ppm [NOS], mM n (unpaired e) 
WT  0.041 1.00 3.9 
His  0.040 1.26 3.3 
Phe  0.057 1.16 4.4 
Tyr  0.062 1.38 4.1 
 
Redox Titrations 
 In order to fully characterize the electronics of the ground state of each enzyme’s 
active site, a measurement of the heme (Fe3+/2+) reduction potential is necessary. 
Determination of the reduction potential of a redox active center is not always 
straightforward, particularly when the complex of interest is buried within a protein 
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scaffold. The backbone of a protein is made mostly from insulating C-C and C-N bonds 
and is designed to discourage random electron transfer reactions in favor of one particular 
function of the enzyme. Nature must find the balance between discouraging deleterious 
redox reactions and promoting productive reactions. The presence of the protein scaffold 
buries the active site and in most cases prevents communication with electrodes, 
rendering standard electrochemical techniques useless. Small molecules, however, which 
can freely diffuse through solution, can still react with most metal sites within proteins. 
For this reason, chemical redox titrations are the method of choice for measuring 
reduction potentials.  
For chemical redox titrations no electrodes or potentiostats are required; however, 
spectroscopic handles are necessary to indicate that a redox process has occurred. Many 
metalloproteins have absorption bands in the visible region, making them amenable to 
characterization by UV-visible spectroscopy. Provided there are wavelengths where the 
two redox forms show characteristic absorption bands, relative protein concentration can 
be measured. A chemical oxidant/reductant is employed with a known reduction potential 
near (within ±100 mV) the expected potential of the protein under analysis, in this case 
Ru(acac)3 with a Ru3+/2+ reduction potential of -275 mV vs. NHE. This feature is required 
for the measurement of a precise equilibrium constant in Equation 3.6 as sub-
stoichiometric reactions will be observed. A small molecule chemical titrant must be 
designed to have desirable UV-visible absorption properties so as not to obscure the 
changes taking place with the enzyme as well as a potential close to that of the sample in 
order to observe equilibrium between the two. However, if the titrant has clear optical 
changes upon change in oxidation state, it too can be used to calculate the concentration 
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of each species in solution. Equation 3.6 is employed, where E is the difference between 
the reduction potential of the titrant and the protein, and E0 is the reduction potential of 
the titrant itself.  
First, the optical spectra of Ru(acac)3 were recorded at various potentials using a 
standard spectroelectrochemical cell (CH Instruments) (Figure 3.15). A solution of 95 
µM Ru(acac)3 in 150 mM NaCl, 50 mM Tris, pH 7.5 was made and degassed to remove 
oxygen from solution. The potential was held at -400 mV vs. the Ag/AgCl reference 
electrode (about -200 vs. NHE) for a few minutes to allow full equilibration and the first 
spectrum (in red) was recorded. The potential was then stepped in 20 mV increments (10 
mV when nearing the reduction potential of the compound) to the negative, each time 
several minutes were allowed for full equilibration of the solution before a UV-vis 
spectrum was recorded. This was continued until no further optical changes were 
detected (the final spectrum is shown in purple). These data confirm the reported 
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case here. Reliable potentials were determined for wild type (-362 ±5 mV) and W70H (-
339 ±5 mV). These numbers are both within 100 mV of the potential of the chemical 
titratrant, Ru(acac)3. The other two mutant enzymes, however, should have significantly 
lower potentials as the thiolate ligand becomes a better donor to the iron as literature 
suggests.38 This would lead to stoichiometric reaction with the Ru complex. If 
equilibrium cannot be observed, the potential of the iron site cannot be determined. This 
was in fact the case, as only stoichiometric oxidation of the iron was observed and no 
measure of the Keq could be obtained for W70F and W70Y. It is sufficient to conclude 
that removal of this strategic hydrogen bond donor substantially decreases the reduction 
potential of the center, consistent with the lack of stability in the ferrous-CO complexes 
of these two mutants.  
 It is also of note that the potentials measured for wild type and W70H are not as 
expected from previous work.58 The potential of most NOS enzymes falls between -240 
and -270 mV vs. NHE. One exception to this is mammalian inducible NOS which has a 
potential near -350 mV without substrate present.16 This is too negative to be reduced by 
the flavins in the NOS reductase domain. Upon introduction of the substrate, the potential 
shifts up toward -250 mV and the iron center can now be reduced by the flavins. In other 
mammalian forms, the presence of calcium ions regulates electron transfer between the 
two domains. In its absence, the oxygenase domain and reductase domain are too far 
separated for electron transfer to occur. In inducible NOS, the activity of which is 
independent of calcium ion concentration, it is this redox switch that most likely prevents 
deleterious side reactions. (If the heme center is reduced without substrate present, 
reactive oxygen species are formed which can damage the cell. However, if the heme is 
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only reduced when the substrate is present, this unproductive reduction event is avoided.) 
This is the first measurement of the reduction potential of any bacterial NOS. These 
enzymes may be regulated in a manner similar to inducible NOS, which is fitting in light 
of their lack of dedicated reductase domain.  
 The potential of the histidine-containing mutant lies positive of the wild type 
enzyme. This same effect was seen in inducible NOS, where the corresponding mutation 
(W188H) shifts the potential positive by 88 mV (as opposed to only 20 mV as seen here). 
It may be that the tighter fold of gsNOS alters this interaction relative to inducible NOS. 
The histidine may not come into as close contact as the tryptophan, or the electronics of 
the porphyrin ring may be affected in a unique way. A crystal structure of these mutant 
enzymes would aid in this discussion. Samples have been sent to the lab of Brian Crane 
at Cornell, however crystals of NOS are notoriously difficult and slow-growing. Efforts 
to determine the structure of these three new mutants are ongoing.  
 
3.5 Conclusions 
 The thermodynamics of wild type and three mutants of gsNOS were characterized 
by various methods. Data from circular dichroism spectroscopy show that mutations at 
position 70 do not decrease the overall stability of the protein fold. The evidence from 
multiple techniques is clear, however, that these mutations significantly affect the 
electronics of the heme center. It was shown using binding assays, generation of the 
ferrous-CO species, and redox titrations that the σ-donating abilities of the thiolate are 
increased after removal of the hydrogen bonding group in the Trp. Both chemical redox 
titrations and instability of ferrous-CO complexes of the two mutants lacking this key 
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hydrogen bond (W70F and W70Y) suggest that they have more negative reduction 
potentials that the two mutants with this hydrogen bond (wild type and W70H). Evans 
methods NMR was used to confirm the results of UV-visible spectroscopy which suggest 
that removal of this hydrogen bond shifts the heme center toward the high-spin state due 
to strengthening of the Fe-S bond, as seen in the binding assays.  
 It can be concluded that this universally-conserved tryptophan residue serves 
several roles, but positioning of the heme within the protein (as has been suggested for 
cyt. P450s) is not one of them. In order to produce NO the electronics of the heme center 
must be tuned in such as way as to stabilize high-valent iron species for the oxidation of 
substrate. During catalysis, the site must also be tuned not only to support six-coordinate 
ferrous-oxy complex, but promote release of NO· from the heme in the end. If the 3/2+ 
reduction potential of the site is too negative, the ferrous-oxy may be unstable or the 
high-valent iron species too stable to perform the desired reactivity. If too negative, 
release of NO will be disfavored and decrease the rate of release to undesirable levels. 
The reactivity of these mutants will shed further light on the role of this key hydrogen-
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The heme-thiolate enzymes cytochromes P450, chloroperoxidase, and nitric oxide 
synthase all activate dioxygen to oxidize substrates. In each of these enzymes, there is a 
conserved hydrogen bonding network around the proximal thiolate ligand. These 
hydrogen bond donors come predominantly from backbone amide groups and help to 
tune the electronics of the heme center. However, in nitric oxide synthase one of these 
three hydrogen-bond donating groups comes from the side chain of a tryptophan residue, 
making nitric oxide synthases unique. Three mutant forms of the nitric oxide synthase 
from Geobacillus stearothermophilus were expressed in E. coli. These mutants each have 
a single point mutation, converting this native tryptophan residue to a histidine, 
phenylalanine, or tyrosine. The reactivity of each the wild type enzyme and the three new 
mutants were tested using stopped-flow mixing coupled with UV-visible absorption 
spectroscopy and the Griess Assay. Autoxidation rates measured by stopped-flow suggest 
that the Tyr and Phe mutants do indeed have significantly more negative reduction 
potentials, but that the His mutant is particularly slow to oxidize. The Griess Assays 
showed that all four enzymes produce nitrite in solution, when provided with substrate, 
cofactor, and hydrogen peroxide (as a source of reducing equivalents). In single turnover 
experiments, however, only three of the four enzymes showed evidence of ferric-NO 
production. The His mutant showed no intermediate absorbance near 440 nm (which 
would be indicative of ferric-NO formation), suggesting that it releases NO- rather than 





As stated previously, nitric oxide synthases are the family of enzymes responsible 
for production of the signaling molecule NO.1-2 It was shown by Moncado3 that the active 
biological signaling molecule is in fact NO· and not any other NOx species. It is this 
molecule that induces relaxation of the cells lining the walls of blood vessels, thus 
regulating blood flow in mammals. Since that time, the field of NO signaling has grown 
rapidly and it is now known that nitric oxide is also involved in neurotransmission, the 
immune response, and apoptosis.1-2, 4  
This family of enzymes makes NO from arginine (Arg) in two turnovers, through 
the enzyme-bound intermediate N-hydroxyarginine (NOHA) (Scheme 4.1).5-6 Much of 
what is known about its catalytic cycle is similar to the well-studied cytochrome P450.7-8 
The observed intermediates (as well as probable intermediates in blue) are shown in the 
cycle in Scheme. 4.2.  
The resting state of the enzyme is a ferric heme with a loosely coordinated water 
molecule.9 This is displaced sterically when substrate binds within the enzyme, forcing a 
five-coordinate complex and shifting the iron to the high spin state. The heme is then 
reduced (in mammalian systems, reducing equivalents come from a dedicated reductase 
domain fused into the same polypeptide chain) to form a ferrous-heme complex. Reduced 
iron species readily bind dioxygen in biological systems. The ferric-oxy species (or 
ferric-superoxo depending on assignment of electrons, as shown by the equilibrium at the 
bottom of the cycle in Scheme 4.2) in cytochrome P450 is reduced by another electron 
from the reductase domain. NOS is unique in that this electron comes from a redox active 
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Another common method used to characterize NO production is called a Griess 
Assay. In aqueous solution, nitric oxide rapidly reacts to form nitrite and other NOx 
species.6 Reagents were developed to react specifically with nitrite, again in aqueous 
solution, in order to spectroscopically characterize in vivo NO production (Scheme 4.4).15 
Reagent B reacts with NO2- (nitrite) to form a diazonium salt, which then reacts with 
Reagent A to form an azo dye with an intense visible absorption band at 540 nm. The 
molar absorptivity of this band is known so it can be used to determine the amount of 
nitrite in solution.  
Both stopped-flow UV-vis spectroscopy and the Griess Assay were used to 
investigate the kinetics and reactivity of a series of mutant enzymes of nitric oxide 
synthase. The NOS used in these studies is that from Geobacillus stearothermophilus 
(gsNOS).16-17 This particular organism is a bacterial thermophile, and therefore its 
enzymes have been optimized to function at elevated termperatures. This adds to the 
stability of their fold,15 a notorious problem for the mammalian nitric oxide synthases. 
This enzyme, gsNOS, has a particularly stable ferrous-oxy intermediate. In the absence of 
substrate, rate constant for its decay is less than 0.1 s-1. This has led to its use in other 
studies, such as the experiments conducted by Davydov and Hoffman which give the 
only evidence for both of the blue intermediates shown in Scheme 4.2.12-13  
The mutants investigated in the studies presented here have been introduced 
previously (see Chapters 1 and 3, Figure 4.1). The role(s) of the proximal hydrogen 
bonding network involving the axial thiolate ligand were investigated. Three mutant 
enzymes, W70H, W70F, and W70Y, were expressed and their reactivity (along with the 
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4.3 Materials and Methods 
Sample Preparation 
The plasmid for the nitric oxide synthase from Geobacillus stearothermophilus 
was a gift from the lab of Brian Crane. This enzyme was expressed as previously 
described by Sudhamsu and Crane with no significant deviations in procedure.15 The 
enzyme was overexpressed in Escherichia coli BL21 (DE3) cells. Cells were grown to an 
optical density of approximately 1.0–1.4 and induced by adding a solution containing 
iron(III) chloride, IPTG, and δ-aminolevulinic acid (Aldrich) to final concentrations of 
125 mg/L, 100 µM, and 50 mg/L, respectively, in milliQ water. The pETDuet vector 
(Novagen) coded for a C-terminal cleavable His6-tag so samples were purified using 
metal affinity chromatography. (This vector also confers chloramphenicol resistance to 
the cells, so 34 µg/mL of this antibiotic were added to all cultures in Luria broth.) The 
His6-tag was then cleaved using bovine thrombin (Calbiochem). Both thrombin and the 
His-tag were removed using size exclusion chromatography. Sample purity and Soret 
band epsilon values were determined through use of the hemochromagen assay.  
A QuikChange site-directed mutagenesis kit from Stratagene was used to make 
the desired mutations in the amino acid backbone. Primers were designed according to 
the guidelines outlined by the QuikChange kit manual. Unless otherwise noted, protein 
solutions were made in the following buffer: 50 mM Tris (2-amino-2-hydroxymethyl-
propane-1,3-diol), 150 mM NaCl, pH 7.5 (the same buffer used for size exclusion 
chromatography). Steady-state UV-visible spectra were collected on an Agilent HP 8452 




Stopped Flow UV-Visible Spectroscopy   
Samples were prepared anaerobically and transferred to an anaerobic tonometer 
with 1.5 equivalents of dithionite to scavenge any residual oxygen. Dithionite was used to 
scavenge oxygen from the stopped flow spectrophotometer (HiTech Scientific) syringes 
and excess dithionite was removed by repeated washing with anaerobic buffer. For 
autoxidation rates, samples of reduced protein (4–6 µM gsNOS) free of substrate and 
pterin cofactor were mixed with aerated buffer. Autoxidation rates were also measured in 
the presence of 2.5 mM Arg and 15 µM pterin. Protein samples for single turnover 
experiments (4–6 µM gsNOS loaded with, 60 µM H4B and 200 µM N-hydroxy-L-
arginine) were rapidly mixed with air-saturated buffer. All experiments were conducted 
at 4 °C. The formation and release of NO in the single turnover experiments was 
monitored using a diode array detector and the rates fit globally using SpecFit32 (HiTech 
Scientific). Measured rates were independent of protein concentration under experimental 
conditions and all measurements were repeated at least six times before averaging. 
Griess Assay 
In order to quantify turnover in each of the enzymes, NO production was 
monitored using the Griess Assay. Reagents A and B were purchased from Cayman 
Chemicals. Solutions were made containing of 100 µL of 30 µM NOS and 1 mM 
arginine in 150 mM NaCl, 50 mM Tris buffer at pH 7.5. To these solutions, 2 µL of 1M 
H2O2 was added to a final concentration of 20 mM. The solution was allowed to react for 
three minutes before addition of Reagent B, which stops the reaction and denatures the 
protein. The sample must be allowed to sit for ten minutes before addition of Reagent A 
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Calculated rate constants for conversion of the ferrous-oxy intermediate to the ferric 
resting state (from SpecFit software) are shown in Table 4.1.  
 
Table 4.1. Rate constants for oxidation of each mutant 
enzyme, with and without substrate/cofactor. 
Sample  Oxidation rate,  s-1  With substrate, s-1  
WT  0.096 0.51 
His  0.0098 0.19 
Phe  0.23 2.6 
Tyr  0.62 4.3 
 
 The effect of the presence of arginine and the pterin cofactor is apparent from 
Table 4.1.  The rate constant for oxidation of the wild type enzyme is increased by the 
smallest amount among the four enzymes, a factor of approximately 5, while the W70H 
mutant oxidizes faster in the presence of these two additional substances by a factor of 
nearly 20. This is a remarkable increase. The data show that the ferrous-oxy species of 
the W70H mutant is much more stable than the others, by an order of magnitude or more, 
but this effect is lessened under catalytic conditions where reactivity of the enzyme 
toward substrate dominates the kinetics rather than simple oxidation of the iron center.  
 Assuming that all four samples interact with dioxygen in the same manner, the 
rates of autoxidation of the heme should correlate with the reduction potentials. This is 
consistent with results from Chapter 3 showing that the reduction potential of the Phe and 
Tyr mutants are significantly more negative than wild type and W70H. The presence of 
this single, long hydrogen bonding interaction brings the reduction potential more 
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positive. The potential of the W70F and W70Y mutants is most likely too negative to 
allow reduction by a reductase enzyme in vivo.   
Griess Assay 
 The function of nitric oxide synthases is to produce nitric oxide. This radical 
species reacts rapidly in aqueous solution, making it difficult to quantify NO production. 
One of the compounds that NO forms in buffered solutions is NO2-, nitrite. A 
colorimetric assay for this species has been developed and patented, allowing for the 
facile determination of nitrite concentrations in solution. This should be proportional to 
the amount of NO originally formed by the enzyme.  
 
Table 4.2. Nitrite production rates by gsNOS mutants.  
Sample  NO2- production, heme-1  min-1  x 100  
WT  10.7 ± 0.6 
His  13.9 ± 0.7 
Phe  4.3 ± 0.1 
Tyr  3.4 ± 0.1 
 
 With wild type as a benchmark, W70H shows increased nitrite production while 
W70F and W70Y show a marked decrease in production. This decrease could be caused 
by any of several things. First, if a mutant produces NO at a decreased rate, this would 
lead to decreased consumption of reducing equivalents from the hydrogen peroxide and 
less nitrite in the solution. Alternatively, if the electronics of the system have been 
unbalanced, a decrease in quantity of nitrite could mean similar or even increased 
consumption of reducing equivalents, but with uncoupling of this from NO production. 
The enzyme would instead release superoxide or other compounds, or even oxidize parts 
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of the protein itself leading to degradation. Unfortunately, the Griess Assay can tell us 
only the amount of nitrite in any given aqueous solution.  
Hydrogen peroxide has sufficient driving force to reduce all four of these protein 
samples (-680 mV). Upon mixture with the enzyme, a ferric-hydroperoxo species is 
formed (the first complex in blue in Scheme 4.2). Due to their more negative reduction 
potentials, the Tyr and Phe mutant enzymes autoxidize very rapidly. This means that their 
rate of consumption of reducing equivalents should be equal or even increased compared 
with wild type regardless of catalytic activity. Without this conserved hydrogen bond, the 
hydroperoxo complex may react too quickly to release reactive oxygen species and the 
ferric enzyme without reacting with the substrate. Alternatively, with a better donating 
thiolate ligand, O-O bond cleavage may occur incredibly rapidly. This would form 
Compound I (second species in blue in Scheme 4.2) and facilitate the first turnover, but 
perhaps not provide enough time for the ferric-hydroperoxo to react with NOHA in the 
second turnover, preventing NO formation. Catalysis using hydrogen peroxide as 
reductant and the source of dioxygen has been shown to produce cyano-ornithine in 
mammalian inducible NOS rather than citrulline (and NO).19  
Single Turnover Experiments 
 To observe turnover of the enzyme, stopped-flow mixing was employed coupled 
with UV-visible absorption spectroscopy for detection of intermediates. The resting state 
of the enzyme, with substrate and cofactor bound, has a Soret band with a maximum 
absorption at 396 nm. The position of this band is very consistent across isoforms, while 
the substrate and cofactor-free forms can vary from 400 (gsNOS)15 to 421 nm 
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and k2. Despite k1 incorporating many elementary steps, this model for fitting the kinetics 
data fits all spectra well using the SpecFit software.  
In all cases the first trace shows the five-coordinate ferrous species, prior to 
formation of the ferrous-oxy. This arises due to the use of excess reductant, which is 
necessary to ensure that the enzyme remains fully reduced in the syringe. The reductant, 
sodium dithionite, reacts several orders of magnitude more rapidly with oxygen than the 
enzyme.24 Thus, the small excess of dithionite (less than 1 equivalent of the enzyme so as 
not to greatly alter the initial concentration of oxygen in solution) will react completely 
before the other chemical reactions occur. Typical traces for the wild type enzyme are 
shown in Figure 4.4 below. The ferrous complex can be seen in the first (and only the 
first) trace, red. The second trace, in green, corresponds well with formation of the 
ferrous-oxy complex. This formation is complete before the second trace can be 
collected, thus the rate is too fast to be calculated accurately from these data. For all 
kinetics analyses the first spectrum is discarded, as this is the only spectrum where the 
ferrous-unligated complex is visible. In every case the spectra first red-shift (relative to 
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some NOx at a rate actually increased relative to wild type. These data together suggest 
that the W70H mutant enzyme does not release NO· but rather NO- from the heme center. 
The other three enzymes, however, clearly form ferric-NO complexes, as observed by 
stopped-flow.   
 
4.5 Conclusions 
 Stopped-flow coupled with UV-visible spectroscopy was employed to 
characterize wild type gsNOS and these three new mutant enzymes. It was shown that 
their autoxidation rates correlate with reduction potential data discussed in Chapter 3. 
The histidine mutant has an elevated reduction potential and the slowest autoxidation rate 
relative to the other three. The wild type is more negative by approximately 20 mV with a 
potential of -362 mV vs. NHE. This reduction potential is similar to that of mammalian 
inducible NOS, but these two are then more negative than other NOS enzymes by 100 
mV.26 The reason for this behavior in gsNOS is unknown, but in iNOS the presence of 
the substrate sterically excludes a water molecule that coordinates the heme and this 
binding event shifts the reduction potential into the normal range for NOSs. The two 
mutants lacking this conserved hydrogen bond, W70F and W70Y, have significantly 
more negative potentials and were found to have very fast rate constants for autoxidation, 
consistent with more negative potentials. 
 The production of NOx species of all four enzymes was characterized by the 
Griess Assay. The wild type produces nitrogen oxide species at a rate similar to other 
NOSs. The W70H mutant has an elevated rate of NOx release/formation. The two 
mutants without this hydrogen bond have significantly decreased rates of NOx 
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production. Clearly this hydrogen bond plays a role in the rate of NO release from the 
enzyme or the speed with which it is formed (as all four should react sufficiently rapidly 
with hydrogen peroxide for reduction not to be a factor).  
 Finally, stopped-flow was once again employed in order to determine if the Griess 
Assay was indeed detecting NO· or rather NO- which are indistinguishable by that 
method. The ferric-NO complex, the immediate precursor to the nitric oxide product, was 
observed for three of the four enzymes. Interestingly, this could not be observed for the 
W70H mutant. This mutant most likely releases NO-.  
 The conserved proximal hydrogen bond donating group found near the axial 
thiolate ligand in all nitric oxide synthases plays a key role in tuning the electronics of the 
active site. This is a uniquely long hydrogen bonding interaction between this tryptophan 
and the thiolate, at just 3.7 Å. Without this interaction, the enzyme is still capable of 
producing NO, as found for both the W70F and W70Y mutants by single turnover 
experiments. Their reduction potentials, however, are incredibly negative and most likely 
fall far below the biologically relevant window. The replacement of this tryptophan with 
a histidine results in an enzyme with a more elevated potential, however it cannot release 
NO radical. The histidine residue, lacking the aryl ring, most likely cannot π-stack with 
the porphyrin ring, giving it more flexibility. This may allow it to move closer to the 
thiolate to improve this hydrogen bonding interaction. If this interaction is too strong, 
NO- is released.  
In the second turnover of the catalytic cycle, an electron from the heme center 
must be shuttled back into the tetrahydrobiopterin cofactor to re-reduce it. The potentials 
of both the heme and the pterin must be tuned perfectly to allow forward electron transfer 
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into the ferrous-oxy complex followed by back electron transfer into the pterin. This back 
electron transfer allows release of NO· and not NO-.27 If the potential of the heme center 
is too high, this back electron transfer cannot occur, preventing NO· release. Thus, the 
hydrogen bonding interaction is necessary for tuning the reduction potential high enough 
for the reduction of the heme by a reductase domain/enzyme. However, when too strong, 
the potential is tuned too high to send an electron back into the pterin after catalysis, 
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5.1 Abstract   
Nitric oxide synthases (NOS) are a family of enzymes responsible for the 
production of the signaling molecule nitric oxide (NO). The rate at which NO is released 
by each enzyme varies greatly among isoforms and species, over nearly two orders of 
magnitude. One residue (an isoleucine located above the heme in bacterial enzymes) 
involved in the gating of NO release has been previously identified by Stuehr. However, 
this single residue does not account for the entirety of the differences among the forms of 
NOS. Another residue, a histidine at position 134 in NOS from Geobacillus 
stearothermophilus (gsNOS), was hypothesized to also participate in gating NO release 
based on an observed correlation between rates of NO release and the bulk of side chains 
at this position. Each single point mutation, H134S and I223V, and the double mutant 
were expressed in gsNOS and their reactivity toward the diatomic molecules CO and NO 
were studied. CO rebinding was investigated using laser flash photolysis and NO release 
using stopped flow UV-visible spectroscopy. The presence of both monomer and dimer 
was observed in solution and position 134 was shown to be another key residue in gating 
NO release. Wild type gsNOS contains both the bulkier Ile223 and His134 and has the 
slowest measured NO release (0.039 s-1) of all NOS enzymes. Each single mutation 
increased NO release substantially, while the double mutant has a rate constant of 1.0 s-1, 
nearly as fast as mammalian iNOS at 2.3 s-1, identifying position 134 as another 




5.2 Introduction  
Nitric oxide synthases (NOS) are found in all eukaryotes, as well as a selection of 
prokaryotes, and are responsible for biological production of nitric oxide (NO).1-2 In 
mammals, various isoforms of NOS are involved in processes such as neurotransmission 
and vasodilation.3 Interestingly, the immune system uses high levels of NO to kill 
invading bacterial cells. Given this function of NO, the discovery of NOS-like enzymes 
in bacteria was unexpected. The role of NO in these bacteria is still under debate, 
although it has been proposed to be a method to combat host immune responses.4-6 
Different functions most likely require different rates of NO release in cells. This can be 
controlled through several methods such as regulation of protein expression within a cell 
(as is the case for mammalian inducible NOS found in macrophages) or on the molecular 
level within the enzyme. These studies focus on the latter, namely the manner in which 
the enzyme itself regulates NO release.  
Nitric oxide synthases contain a thiolate-ligated heme active site, very similar to 
that found in cytochromes P450.7-8 This superfamily of enzymes carries out a vast array 
of biological oxidations, using the heme cofactor to activate dioxygen.9 NOS, on the 
other hand, catalyzes only the oxidation of arginine to produce NO in two turnovers 
(through the enzyme-bound intermediate N-hydroxy-L-arginine). The first turnover 
involves a two-electron oxidation of substrate like cytochromes P450, while the second is 
formally a three-electron oxidation and is unique in biology.10-11 What is known of the 
catalytic cycle is shown in Scheme 5.1 colored black. The two species in blue are 
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corroborated.12) However, multiple groups have demonstrated ferric-NO formation and 
its decay to release the radical species. In mammals, a series of complex steps has 
evolved in order to regulate enzyme function and keep tight control on each step, such as 
delivery of electrons and the tuning of redox potentials.13 It is not fully understood how 
the protein matrix controls NO release and what factors cause this rate to vary among 
forms of NOS enzymes, nor how NO production is controlled in bacterial systems.   
In order to study NO release, stopped flow UV-visible spectroscopy has been 
employed. The unique spectroscopic features of heme enzymes allow for the 
differentiation of various species during catalysis. Single turnover experiments, where the 
fully-reduced, substrate-bound enzyme is held in de-oxygenated buffer and then mixed 
rapidly with buffer that is saturated in oxygen, have allowed the determination of rates of 
NO release in many NOS enzymes.14-17  
It was observed in such stopped flow measurements that while the mammalian 
NOS isoforms release NO on the order of 2 to 5 s-1, many bacterial enzymes release NO 
about one order of magnitude slower.16 Crystallographic studies reveal a valine residue in 
mammalian forms which is replaced with an isoleucine in many bacterial forms.18-20 This 
isoleucine is within Van der Waals contact of any diatomic bound at the iron center. 
Stuehr and coworkers showed that installation of an isoleucine at this position in the 
mammalian inducible NOS slows the rate of NO release, while removal of this methyl 
group through mutation to a valine in the bacterial NOS from Bacillus subtilus increases 
its rate of NO release.16 While this is an important finding, the rate constants do not 
change by the full order of magnitude that separates them (in iNOS, 2.3 s-1 slows to 0.77 
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and in bsNOS 0.23 increases to 0.82). Clearly additional factors modulate the rates of NO 
release.    
Flash photolysis is another technique commonly used to study the interactions of 
diatomic molecules with proteins.21-23 Most heme centers form stable complexes with 
carbon monoxide (CO) in the ferrous state.7, 24 While indefinitely stable in the dark, when 
exposed to visible (green) light the iron-carbon bond of the ferrous-CO species is broken, 
liberating CO and transiently generating a five coordinate ferrous heme. Under an 
atmosphere of CO, the six-coordinate species is reformed.25 Due to large differences 
between the absorbance spectra of the five- and six-coordinate heme species, transient 
absorption spectroscopy is again an ideal technique for observing reactivity.25-26 CO is 
used preferentially over NO and O2 because it alone is redox inactive. Exposure of 
reduced enzyme immediately leads to oxidation of the iron center. The lifetime of a 
ferrous-oxy species is incredibly short (milliseconds to seconds at best). Nature has been 
forced to take steps to prevent this reaction in order to prevent the release of superoxide 
into cells. If the protein is reduced when substrate and cofactor are not present, 
superoxide will certainly be released, leading to cellular damage. NO also undergoes 
redox chemistry with the ferrous iron to oxidize it. CO is the closest mimic that will not 
undergo the same chemical reactions. The interactions of CO with myoglobin,27-30 
microperoxidase-8,31 human myeloperoxidase,32 and cytochrome P45033-35 have been 
previously studied extensively. It was found that CO is a good mimic for the study of 
oxygen binding to these biologically important proteins.24, 29  
Both flash photolysis and stopped flow coupled with transient UV-visible 
spectroscopy were used to study the interactions of diatomics with the nitric oxide 
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synthase from Geobacillus stearothermophilus (gsNOS).36-37 The wild type enzyme, with 
isoleucine in position 223 (gsNOS numbering) directly above the heme as is commonly 
found in bacterial enzymes, as well as three other mutant species were studied by both 
techniques. Site-directed mutagenesis was used to insert a valine at position 223, as 
previously demonstrated in bsNOS to increase the rate of NO release. Mutations were 
also made at position 134.  
We have observed a correlation between reported rate constants of NO release in 
the literature with residues found at this position. We will call these two positions gates. 
bsNOS has a histidine residue at this alternate position and has a particularly small rate 
constant of 0.23 s-1, while the NOS from Deinococcus radiodurans, also bacteria, has a 
larger release rate constant of 0.50 s-1 and a smaller alanine residue at this second gate.38 
Both bacterial enzymes have an isoleucine in the first gate, keeping the overall rate 
smaller than mammalian forms. The NOS from mammalian neurons,39 however, has a 
larger release rate constant of 5 s-1 and both gating positions contain smaller residues, 
valine near the heme and a serine corresponding to position 134 in gsNOS. The enzyme 
with the fastest recorded release rate constant comes from the bacterium Sorangium 
cellulosum17 which has a valine above the heme and glycine at the second gate, and 
releases NO at a rate of 7–10 s-1. Clearly, smaller residues at these two positions correlate 
with faster release of NO, while bulkier groups at 134 and 223 slow down NO release.  
A series of four variants of gsNOS were expressed: wild type, I223V, H134S, and 
the double mutant H134S/I223V. The wild type enzyme with the bulkier side chains was 
found to have the slowest reported NO release rate of 0.039 s-1 by stopped flow 
spectroscopy. Each single mutant increased this rate constant substantially, I223V to 0.30 
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s-1 and H134S to 0.16 s-1. The double mutant increased the rate of NO release to 1.0 s-1, 
nearly the same as the mammalian isoforms. These data show that position 134 is in fact 
another residue key to enzymatic regulation of NO release, along with the known 
valine/isoleucine mutation. These results, together with CO flash photolysis studies 
provide a clear picture of the interactions of both NO and CO with this biologically 
important enzyme. 
 
5.3 Experimental Methods 
Sample Preparation  
The plasmid for the nitric oxide synthase from Geobacillus stearothermophilus 
was a gift from the lab of Brian Crane. This enzyme was expressed as previously 
described by Sudhamsu and Crane with no significant deviations in procedure.36 The 
enzyme was overexpressed in Escherichia coli BL21 (DE3) cells. Cells were grown to an 
optical density of approximately 1.0–1.4 and induced by adding a solution containing 
iron(III) chloride, IPTG, and δ-aminolevulinic acid (Aldrich) to final concentrations of 
125 mg/L, 100 µM, and 50 mg/L, respectively, in milliQ water. The pETDuet vector 
(Novagen) coded for a C-terminal cleavable His6-tag so samples were purified using 
metal affinity chromatography. (This vector also confers chloramphenicol resistance to 
the cells, so 34 µg/mL of this antibiotic were added to all cultures in Luria broth.) The 
His6-tag was then cleaved using bovine thrombin (Calbiochem). Both thrombin and the 
His-tag were removed using size exclusion chromatography. Sample purity and Soret 
band epsilon values were determined through use of the hemochromagen assay.  
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A QuikChange site-directed mutagenesis kit from Stratagene was used to make 
the desired mutations in the amino acid backbone. Primers were designed according to 
the guidelines outlined by the QuikChange kit manual. Unless otherwise noted, protein 
solutions were made in the following buffer: 50 mM Tris (2-amino-2-hydroxymethyl-
propane-1,3-diol), 150 mM NaCl, pH 7.5 (the same buffer used for size exclusion 
chromatography). Steady-state UV-visible spectra were collected on an Agilent HP 8452 
diode array spectrophotometer.  
For laser experiments, oxygen-free samples were pumped into an anaerobic 
chamber (with an atmosphere of 100% N2) and reduced under excess dithionite. A small 
excess of dithionite was left in samples in order to ensure that the heme center remained 
in the reduced, ferrous state throughout the entirety of the experiment. Samples were then 
placed in a quartz cuvette (Starna Cells) with a graded seal connecting the cuvette to a 
Köntes valve, enabling the secure sealing of the cuvette from atmosphere. The cuvettes 
were then sealed and removed from the anaerobic chamber. The side arm of the cuvette 
was attached to a Schlenk line and evacuated and backfilled with carbon monoxide 
(100% or 20% with 80% N2) three times. Once the side arm was under the desired 
atmosphere of CO, the Köntes valve was opened to the side arm. The headspace of the 
cuvette, above the protein solution, was evacuated and back-filled with CO from the 
Schlenk line three times and sealed under this new atmosphere. The sample was gently 
shaken over night, in the dark, at 4 °C to allow for full equilibration of the atmosphere 
with the solution. Inadequate equilibration time resulted in irreproducibility between 
samples.   
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Formation of the ferrous-CO complex was confirmed using its characteristic 
absorption band at 446 nm. The stability of the sample was monitored by UV-visible 
spectroscopy after its generation, and immediately before and after laser irradiation. No 
samples showed significant degradation after irradiation by the laser.  
Nanosecond Transient Absorption Spectroscopy 
All transient UV-visible spectroscopic measurements for CO flash-photolysis 
experiments were conducted at the Beckman Institute Laser Resource Center at Caltech. 
For time-resolved measurements, a 10 Hz Q-switched Nd:YAG pulsed laser was used to 
provide 8 ns pulses of irradiation (Spectra-Physics Quanta-Ray PRO-Series). This laser 
was used to pump an optical parametric oscillator, which allows tuning pulses from the 
laser (355 nm output) in the visible region, between 400 and 650 nm (Spectra-Physics 
Quanta-Ray MOPO-700). The details of this setup have been previously described.40 All 
samples were excited with 560 nm laser pulses and exposed to less than 5 mJ/pulse of 
power. All traces are an average of 500 laser shots using 1 nm slits.        
Stopped Flow UV-Visible Spectroscopy   
Samples were prepared anaerobically and transferred to an anaerobic tonometer 
with 1.5 equivalents of dithionite to scavenge any residual oxygen. Dithionite was used to 
scavenge oxygen from the stopped flow spectrophotometer (HiTech Scientific) syringes 
and excess dithionite was removed by repeated washing with anaerobic buffer. Protein 
samples (4–6 µM gsNOS, 60 µM H4B, and 200 µM N-hydroxy-L-arginine) were rapidly 
mixed with air saturated buffer at 4 °C. The formation and release of NO was monitored 
using a diode array detector and the rates fit globally using SpecFit32 (HiTech 
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Scientific). Measured rates were independent of protein concentration under these 
experimental conditions.  
Data Analysis  
Transient absorption traces were converted to optical density using Equation 5.1 
and fit using Igor-Pro graphing software. All data were fit to a double exponential decay 
function, with residuals less than 1% of the signal.  
 
5.4 Results 
Steady-State Spectroscopy  
UV-visible spectroscopy was used to characterize the resting state and to verify 
the formation of the ferrous-carbonyl species of each mutant sample. This technique is 
particularly useful given the sensitivity of heme absorption bands to their environment, 
ligation, and oxidation state. Each enzyme displayed a single Soret peak with an 
absorbance maximum at 446 nm as is typical for nitric oxide synthases and close to that 
of the related cytochromes P450, named for the sharp absorption of their ferrous-carbonyl 
species at 450 nm.7 The spectra of several such forms of the wild type enzyme are shown 
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We also analyzed the effect of these mutations on the pre-exponential factor of 
each rate from the double exponential fit. By introducing these small changes, we appear 
to be altering significantly the amount of the fast and slow phase, relative to one another. 
By introducing a single serine residue near the surface of the enzyme, the ratio of A1 to 
A2 is shifted from 2:1 to 1:2.  
Table 5.2. Relative percentages of each rate constant by mutant. 
100% CO WT I223V H134S H134S/I223V
A1 (t1) 66% 46% 36% 43% 
A2 (t2)  34% 54% 64% 57% 
 
Stopped-Flow UV-Visible Spectroscopy  
NO release rates were measured for each protein sample using single turnover 
experiments. The enzyme was loaded with the redox active cofactor, tetrahydrobiopterin, 
and the substrate N-hydroxyarginine and then reduced using sodium dithionite. These 
samples were prepared anaerobically, sealed in a gas-tight syringe, and mixed with fully 
aerated buffer ([O2] ≈ 258 µM) to initiate turnover. Catalysis was monitored using UV-
visible spectroscopy between 370 and 710 nm, with spectra taken at regular intervals over 
millisecond to second timescales. On faster timescales, the five-coordinate ferrous heme 
complex can be observed in the initial trace due to the excess dithionite present. Nearly 
immediately (within 5 ms, the dead time of the mixer), the ferrous-oxy species is formed; 
this formation is too rapid for stopped-flow spectroscopy to characterize the rate. (Note: 
dithionite reacts with oxygen several orders of magnitude faster than the enzymes under 
study and is therefore completely reacted before the second trace is collected.) The 
ferrous-oxy subsequently forms an intermediate complex, which finally decays to the 
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Further, the amplitudes of each exponential component of the fits are significant, with no 
one component accounting for less than 30% of the signal (Table 5.2). We hypothesized, 
given what is known about nitric oxide synthases and how they differ from other systems 
studied by this method, that we might be observing both the monomer and dimer in 
solution. It is known that NOS functions only as a dimer in mammals and disrupting 
dimerization shuts down catalysis.1 During purification, bands for both monomer and 
dimer were observed on a size exclusion column in the same buffer with the same ionic 
strength. To test this hypothesis, samples were made with varying concentrations and we 
monitored the amplitude of both the faster and slower processes. Table 5.4 shows the 
clear effect of concentration on the amplitudes of the faster and slower signals, consistent 
with the presence of monomer and dimer. Further, the two rate constants are similar in 
magnitude and both on the millisecond timescales, which agrees with both processes 
being second-order recombination with slightly different barriers. Introducing the 
presence of both monomer and dimer would account for the observed behavior of all 
samples.   
Table 5.4. Effects of concentration 
on the relative proportion of the two 
processes. Concentration in µM. 
 
[NOS] A1 A2 
6.1 64% 36% 
9.9 58% 42% 
27 35% 65% 
 
 
Another possibility exists, however, as explanation for two observed millisecond 
processes. In proteins such as hemoglobin, a phenomenon called cooperativity is 
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observed.43-44 When laser irradiation hits the sample, because of the large quantum yield 
for this photochemical process, a high percentage of photodissociation is observed. One 
can imagine a case where the protein exists completely as a dimer in solution and when 
irradiated either one or both bound CO molecules are librated. If cooperativity (or anti-
cooperativity) is a contributing factor, dimers with a single CO molecule still bound 
would have a higher recombination rate constant than those where both are dissociated 
due to changes in protein conformation. In such a situation, the proportion of CO that is 
released from the protein will vary with laser intensity according to a standard power 
dependence and the proportion of the faster rate should decrease. A tenfold increase in 
laser power did not alter the proportion of the two rates observed, it merely increased the 
overall signal strength (Table 5.5).  
 
Table 5.5. Power dependence of the relative amplitudes of each signal. 
Power at sample (mJ/pulse) invτ1 (s-1) invτ2  (s-1) A1 A2 
0.6 91 9.9 x 102 58% 42% 
0.7 91 1.0 x 103 57% 43% 
2.8 88 9.6 x 102 59% 41% 
6.4 87 9.4 x 102 59% 41% 
7.0 87 9.4 x 102 59% 41% 
 
From all these results we conclude that we are in fact observing both the 
monomer and dimer forms of the enzyme under experimental conditions, that both react 
with CO to give a rebinding rate constant on the order of 105 M-1 s-1 as has been found in 
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NO Formation and Release  
In order to determine the effect of these mutations on the NO release rate 
constant, we conducted single turnover experiments in the lab of Prof. Michael Marletta 
at UC Berkeley with the assistance of Dr. Emily Weinert. This allows for the direct 
comparison of our mutations with previously published rates of NO release. The wild 
type enzyme was found to release NO with a rate constant of 0.039 s-1, which closely 
matches the rate constant previously published by Crane and Sudhamsu of 0.04 s-1, under 
the same experimental conditions.36 This enzyme has the smallest reported rate constant 
of all NOS enzymes. Each single mutation (H134S and I223V) increases the rate 
significantly, while the double mutant brings the rate to 1.0 s-1, close to the higher rates 
found in mammalian enzymes (which were measured at a slightly higher temperature). 
The ability of a mutation at position 134 to both increase the rate on its own and to 
further increase the rate beyond the single mutation already known at position 223 (Table 
5.3) confirms that it is in fact another key residue gating NO release.  
Transient Spectra Generated by Modeling 
During the fitting procedure, it was observed that the spectrum generated for the 
intermediate ferric-NO complex is not always consistent. For the fastest mutant, 
H134S/I223V, the ferric-NO species is nearly cleanly resolved, showing a peak near 440 
nm (Figure 5.8). The slower mutants and the wild type enzyme showed a mixture of 
Soret bands (Figure 5.9). The observation of multiple bands like this clearly indicates 
that the model is incomplete — what is being fitted as a single intermediate is actually a 
mixture of species. This has been observed before in both a bacterial NOS and a slower 
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Table 5.6. Full kinetics details of fitting model for each of the four enzymes including a 
comparison of the NO release rate with the three-state model. 
Enzyme Process Rate Constant 3-State Model’s Fit 
Wild Type A > B 8.1 × 10-2  
 B > B1 1.5 × 105  
 B1 > B 8.2 × 104  
 B > B2 1.5 × 103  
 B2 > B 2.9 × 103  
 B > C 0.10 0.04 
    
H134S A > B 1.7 × 102  
 B > B1 1.1 × 106  
 B1 > B 1.4 × 106  
 B > B2 1.6 × 103  
 B2 > B 6.7 × 105  
 B > C 0.31 0.16 
    
I223V A > B 1.0 × 101  
 B > B1 4.9 × 104  
 B1 > B 8.9 × 104  
 B > B2 1.2 × 101  
 B2 > B 1.6 × 103  
 B > C 0.51 0.30 
    
H134S/I223V A > B 1.6 × 101  
 B > B1 1.8 × 104  
 B1 > B 4.1 × 100  
 B > B2 1.4 × 103  
 B2 > B 1.9 × 100  
 B > C 1.9 1.0 
 
 In this model, A is the ferrous-oxy complex as before. Again, the spectrum of this 
species is well known and can be used to verify the accuracy and chemical 
reasonableness of the model and fit. The spectrum of B is specified as the ferric-NO 
spectrum with a maximum absorbance at 441 nm (courtesy of Dr. Joshua Woodward 
from the Marletta group), which is known to form during turnover. The spectrum of C is 
the final resting state of the enzyme, the five-coordinate ferric species. The spectrum 
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generated for one of the two new intermediates is essentially identical to that of the ferric 
resting state. This is consistent with an equilibrium between rapid release and rebinding 
of NO trapped in the binding pocket, which would be very fast when compared with the 
other processes occurring. It is also consistent that this would be seen to the greatest 
extent in the two enzymes with the Ile residue present near the heme. The methyl group 
of this residue is right at Van der Waals contact distance from any diatomoics bound to 
the iron and clearly blocks any exit from the binding pocket (as is clear from the crystal 
structure, PDB file 2FLQ).   
The identity of the other intermediate is less obvious, but at least one reasonable 
possibility exists. The species is clearly formed after the majority of catalysis, being in 
equilibrium with the ferric-NO species. Several other models were applied, but the only 
one that fits the collected data is one where this species is in rapid equilibrium with the 
ferric-NO complex. As seen in Figure 5.10, this species has a Soret maximum near 420 
nm. A species with a similar absorbance has been previously observed under catalytic 
conditions for the first turnover (Arg rather than NOHA was used as substrate).15 This is 
also a slower enzyme, with a Trp to His mutation as discussed in Chapters 3 and 4, but 
made in the mammalian inducible NOS isoform. In this study, the authors proposed that 
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second turnover.45 The observed species may be the product heme complex before 
electron transfer to the pterin. The spectrum is nearly identical (simply 4 nm blue-shifted) 
of the spectrum of HNO-myoglobin.46 However, this cannot be the species observed in 
the study of mammalian NOS, as they were probing the first turnover. An alternative 
explanation is that this 420 nm species is analogous to the P420 species (Chapter 3) 
where the thiolate ligand is protonated and/or dissociates. We may be observing the 
equilibrium between two protonation states of this ligand. Identification of a species 
based solely on a single UV-visible spectrum is difficult at best, but further attempts are 
being made to understand the origin of this spectrum.  
 
5.6 Conclusions 
First, CO is a valuable diatomic mimic for the more reactive dioxygen and nitric 
oxide, however with a caveat. One must remember the conditions under which 
experiments are performed. For CO photolysis, systems are under saturating conditions 
with large excesses of carbon monoxide. This is a good system for comparison with 
oxygen binding to hemoglobin in the lungs. Nitric oxide formation, on the contrary, 
involves the production of a single molecule of NO per protein, far from saturating 
conditions. Further, NO reacts rapidly in aerated aqueous solution, further preventing its 
buildup and keeping the system from reaching equilibrium. Also, the driving force 
ultimately behind each of these processes involves formation or cleavage of two distinct 
bonds. CO is very similar to NO, but on a fundamental level an Fe-N bond is not an Fe-C 
bond. While experiments with CO provide a wealth of information about the overall 
175 
 
kinetics model for reactivity with diatomics, for an NO release rate one must perform the 
single turnover experiments.  
With these experiments, we have confirmed that the isoleucine residue at position 
223 does gate NO release in gsNOS, slowing the decay of the ferric-NO species. We 
have also demonstrated that position 134, occupied by a histidine in wild type gsNOS, 
also gates NO release, with smaller residues at this position corresponding to faster 
release rates. Together, these two positions can account for the majority of the differences 
in rate between any two NOS enzymes. 
Further, we have used a new, more accurate model to fit our data, showing rapid 
equilibrium between the bound and unbound NO, and another unidentified species. This 
species has been previously observed. It was called Compound I. The Compound I in 
cytochromes P450 has a much more blue-shifted Soret band with a maximum near 365 
nm and it reacts much more quickly. It is of note that this species with absorbance at 420 
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The accurate measurement of a protein’s electrochemical properties is an 
important part of understanding its function. Several methods have been developed to 
facilitate communication between deeply buried protein metal centers and electrodes. 
One such technique, protein film voltammetry (PFV), involves the immobilization of 
proteins on the surface of electrodes by various means. Such techniques can result in 
clear signals from proteins, allowing the measurement of not only reduction potentials 
but kinetics as well. Two types of PFV have been employed in the study of the nitric 
oxide sythase from Geobacillus stearothermophilus. First, a mutant of this NOS was 
covalently connected to a gold electrode. It was hypothesized that the use of a 
hydrophilic linker would maintain a normal aqueous environment around the enzyme and 
avoid the shifting of potentials (a common problem in PFV). When it was found that this 
technique still resulted in measuring responses with significantly shifted potentials (as 
compared with those measured by redox titration in solution), a more traditional film was 
employed. The kinetics of gsNOS was studied in DDAB films and compared with the 
mammalian inducible isoform. It was found to show similar behavior, and experiments 
are still underway to further characterize the kinetics of wild type and three mutants of 
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Discrepancies in measured reduction potentials are not limited to cyt. P450s or 
even iron enzymes in general. A chemically modified electrode, cysteamine on Au(111), 
was used to measure the CuII/I potential of the enzyme copper nitrite reductase. The 
authors neglect to specifically mention the measured potential in the report; however, the 
included cyclic voltammograms show a quasi-reversible wave slightly negative of 0 mV 
vs. SCE.11 The same group published later voltammetric studies of the same copper-
containing nitrite reductase, this time using gold electrodes modified not with cysteamine 
but with self-assembled monolayers of alkane thiols.12 They again fail to mention the E1/2 
they measured, but the couple clearly lies at nearly +100 mV vs. SCE. Two different 
monolayers on the same electrode resulted in two different reduction potentials. 
Curiously, these differing potentials go undiscussed but for one mention of differing 
dielectric constants between films and aqueous solution.4 The cause of these shifts 
remains unknown.  
Interestingly, varied electrochemical approaches have produced consistent results 
in other cases. Film voltammetric methods have been used for several small electron 
transfer (ET) proteins, such as cytochromes c and cupredoxins, Figure 6.1. The reduction 
potential cupredoxin azurin, for example, falls near +300 mV vs. NHE regardless of 
electrochemic method.13-15 A trend seems apparent: technique-based discrepancies in 
reduction potential are endemic to larger metalloproteins, but measured values tend to 








































































ation of a p
n electrode























































difficult; only when using a specially designed cell and extensive reflections can one take 
a UV-visible or IR spectrum of a protein within a film.18 Films have successfully been 
employed with a number of enzymes including cyt. P450, myoglobin, and nitric oxide 
synthase.19 A selection of some of the surfactants that have been used for film 
voltammetry is shown in Scheme 6.1.  
 
Scheme 6.1. Surfactants commonly used for protein film voltammetry.  
These surfactants typically contain a polar head group and a long alkyl chain, 
making them similar to lipids and, presumably, cell membranes. Solutions of these 
surfactants in organic solvents are dropped onto polished electrode surfaces and the 
solvent is allowed to evaporate.20 An interlocking network of the surfactant, or a film, is 
left behind. When soaked in an aqueous solution of protein sample, some protein is taken 
up into the film or otherwise interacts with it. This technique has demonstrated the largest 
deviation from solution reduction potentials amongst the many electrochemical 
techniques. The reason for this is hypothesized to be the lipid-like nature of the film. 
Perhaps lipid-like films provide a more accurate measure of the potential of membrane-
bound proteins, although no concrete data support this hypothesis. Unfortunately, 
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detailed characterization of biological samples on solid surfaces is difficult as most 
characterization techniques are solution-based.  
Covalent attachment of the samples of interest can be used to couple the active 
site to the electrode. Mutagenesis to install a single, solvent-exposed cysteine will allow 
for attachment of the protein to a gold electrode directly through the cysteine sulfur atom. 
Alternatively, this cysteine can be used to functionalize the protein with some other group 
for attachment to the surface, as demonstrated by Liu and coworkers.21 Investigators have 
proposed that these methods block movement of the protein and lock it out of potentially 
necessary conformations, particularly with respect to protein-electrode ET pathways.4, 7 
This lack of motion is a concern with all methods that tether the sample to the electrode 
surface. Comparison of the results of voltammetry with both covalent and non-covalent 
attachment to gold electrodes using SAMs should provide insight into the issue of sample 
diffusion on the electrode surface.   
Electrochemistry was carried out using covalent attachment of NOS to standard 
SAMs, but the potential measured was +195 mV vs. NHE, about 450 mV positive of 
other NOS enzymes.22 A hydrophilic SAM terminated in a maleimido functionality was 
then used to attach gsNOS to the surface in a covalent fashion rather than the traditional 
hydrophobic SAMs. It was hypothesized that the hydrophilic SAMs on a gold electrode 
would promote a normal hydration sphere around the protein and prevent the shift in 
potential previously observed in PFV of mammalian iNOS. Cyclic voltammograms were 
collected on gsNOS. This bacterial enzyme displayed similar properties as iNOS, with 
the observable dissociation of water upon reduction of the iron center. Unfortunately, the 
measured potential was again shifted very positive of the potential measured in solution.  
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Given that this technique using covalent attachment still showed altered reduction 
potentials for the iron site, the complicated synthesis and electrode prep were deemed 
unnecessary and further investigations were made using traditional films. Films of DDAB 
and wild type gsNOS were co-deposited onto the surface of basal plane pyrolytic graphite 
electrodes and their electrochemical properties were investigated.  
 
6.3 Materials and Methods  
Electrodes were purchased from Pine Instruments. Chemicals, such as arginine 
and TrisHCl buffer, were purchased from Sigma-Aldrich. The enzymes used in this study 
were expressed and mutated as described previously in Chapter 3.  
A mutant form of gsNOS was expressed, containing a single, solvent-exposed 
cysteine residue for use in covalent attachment. The native enzyme has four cysteine 
residues at positions 76, 161, 227, and 269. Cys76 ligates the iron center and is necessary 
for activity and for heme incorporation. Position 161 is completely buried within the 
protein interior and hidden from solvent. These residues were left un-mutated as they 
should not interfere in any way with the protein labeling process. Positions 227 and 269, 
however, are exposed to solvent at the surface of the protein, so these two residues were 
mutated to serines so as not to interfere with covalent labeling reactions which rely on a 
nucleophilic thiolate. A cysteine was installed near the heme (in order to facilitate 
communication with the electrode) at position 115, where a lysine residue is found in the 
wild type and is fully solvent exposed. SAMs were made with polyethylene glycolated 
(PEG-ylated) thiols in order to produce a hydrophilic surface. This PEG-ylated thiol was 
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Interesting features can be observed in the voltammograms, such as differing 
interactions with the axial water ligand (see Figure 6.9) due to altered electronics of the 
heme site. The trend in measured reduction potentials matches that observed by redox 
titration. Experiments were also carried out with the wild type enzyme at increased pH 
and indicated a shift of approximately 60 mV per pH unit, as is consistent with a proton-
coupled electron transfer event. Given the presence of the water molecule that 
coordinates the heme in the Fe(III) state, but not the Fe(II) state and the possible 
protonation of the axial thiolate ligand, this result was expected. Studies are on-going in 
an effort to characterize the equilibrium for water ligation in each enzyme and the effect 
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7.1 Roles of the Hydrogen-Bond Donating Groups in Tuning the Axial Thiolate 
The thermodynamics of wild type and three mutants of gsNOS were characterized 
by various methods. Data from circular dichroism spectroscopy shows that mutations at 
position 70 do not decrease the overall stability of the protein fold. The evidence from 
multiple techniques is clear, however, that these mutations significantly affect the 
electronics of the heme center. It was shown using binding assays, generation of the 
ferrous-CO species, and redox titrations that the σ-donating abilities of the thiolate are 
increased after removal of the hydrogen bonding group in the Trp. Both chemical redox 
titrations and instability of ferrous-CO complexes of the two mutants lacking this key 
hydrogen bond (W70F and W70Y) suggest that they have more negative reduction 
potentials than the two mutants with this hydrogen bond (wild type and W70H). Evans 
Methods NMR was used to confirm the results of UV-visible spectroscopy which suggest 
that removal of this hydrogen bond shifts the heme center toward the high-spin state due 
to strengthening of the Fe-S bond, as seen in the binding assays.  
 It can be concluded that this universally-conserved tryptophan residue serves 
several roles, but positioning of the heme within the protein (as has been suggested for 
cyt. P450s) is not one of them. In order to produce NO the electronics of the heme center 
must be tuned in such as way as to stabilize high-valent iron species for the oxidation of 
substrate. During catalysis, the site must also be tuned not only to support the six-
coordinate ferrous-oxy complex, but promote release of NO· from the heme in the end. If 
the 3/2+ reduction potential of the site is too negative, the ferrous-oxy may be unstable or 
the high-valent iron species too stable to perform the desired reactivity. If too negative, 
release of NO will be disfavored and decrease the rate of release to undesirable levels.  
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Stopped-flow coupled with UV-visible spectroscopy was employed to 
characterize wild type gsNOS and these three new mutant enzymes. It was shown that 
their autoxidation rates correlate with reduction potential data discussed in Chapter 3. 
The histidine mutant has an elevated reduction potential and the slowest autoxidation rate 
relative to the other three. The wild type is more negative by approximately 20 mV with a 
potential of -362 mV vs. NHE. This reduction potential is similar to that of mammalian 
inducible NOS, but these two are then more negative than other NOS enzymes by 100 
mV. The reason for this behavior in gsNOS is unknown, but in iNOS the presence of the 
substrate sterically excludes a water molecule that coordinates the heme and this binding 
event shifts the reduction potential into the normal range for NOSs. The two mutants 
lacking this conserved hydrogen bond, W70F and W70Y, have significantly more 
negative potentials and were found to have very fast rate constants for autoxidation, 
consistent with more negative potentials. 
 The production of NOx species of all four enzymes was characterized by the 
Griess Assay. The wild type produces nitrogen oxide species at a rate similar to other 
NOSs. The W70H mutant has an elevated rate of NOx release/formation. The two 
mutants without this hydrogen bond have significantly decreased rates of NOx 
production. Clearly this hydrogen bond plays a role in controlling the rate of NO release 
from the enzyme or the speed with which it is formed (as all four should react sufficiently 
rapidly with hydrogen peroxide for reduction not to be a factor in this assay).  
 Finally, stopped-flow was once again employed in order to determine if the Griess 
Assay was indeed detecting NO· or rather NO- which are indistinguishable by that 
method. The ferric-NO complex, the immediate precursor to the nitric oxide product, was 
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observed for three of the four enzymes. Interestingly, this could not be observed for the 
W70H mutant. This mutant most likely releases NO-.  
 The conserved proximal hydrogen-bond donating group found near the axial 
thiolate ligand in all nitric oxide synthases plays a key role in tuning the electronics of the 
active site. This is a uniquely long hydrogen bonding interaction between this tryptophan 
and the thiolate, at just 3.7 Å. Without this interaction, the enzyme is still capable of 
producing NO, as found for both the W70F and W70Y mutants by single turnover 
experiments. Their reduction potentials, however, are incredibly negative and most likely 
fall far below the biologically relevant window. The replacement of this tryptophan with 
a histidine results in an enzyme with a more elevated potential, however it cannot release 
NO radical. The histidine residue, lacking the aryl ring, most likely cannot π-stack with 
the porphyrin ring, giving it more flexibility. This may allow it to move closer to the 
thiolate to improve this hydrogen bonding interaction. If this interaction is too strong, 
NO- is released.  
In the second turnover of the catalytic cycle, an electron from the heme center 
must be shuttled back into the tetrahydrobiopterin cofactor to re-reduce it. The potentials 
of both the heme and the pterin must be tuned perfectly to allow forward electron transfer 
into the ferrous-oxy complex followed by back electron transfer into the pterin. This back 
electron transfer allows release of NO· and not NO-. If the potential of the heme center is 
too high, this back electron transfer cannot occur, preventing NO· release. Thus, the 
hydrogen bonding interaction is necessary for tuning the reduction potential high enough 
for the reduction of the heme by a reductase domain/enzyme. However, when too strong, 
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the potential is tuned too high to send an electron back into the pterin after catalysis, 
which is necessary for formation of the product NO. 
 
7.2 Gating of Diatomics in Nitric Oxide Synthase 
First, CO is a valuable diatomic mimic for the more reactive dioxygen and nitric 
oxide, however with a caveat. One must remember the conditions under which 
experiments are performed. For CO photolysis, systems are under saturating conditions 
with large excesses of carbon monoxide. This is a good system for comparison with 
oxygen binding to hemoglobin in the lungs. Nitric oxide formation, on the contrary, 
involves the production of a single molecule of NO per protein, far from saturating 
conditions. Further, NO reacts rapidly in aerated aqueous solution, further preventing its 
buildup and keeping the system from reaching equilibrium. Also, the driving force 
ultimately behind each of these processes involves formation or cleavage of two distinct 
bonds. CO is very similar to NO, but on a fundamental level an Fe-N bond is not an Fe-C 
bond. While experiments with CO provide a wealth of information about the overall 
kinetics model for reactivity with diatomics, for an NO release rate one must perform the 
single turnover experiments.  
With these experiments, we have confirmed that the isoleucine residue at position 
223 does gate NO release in gsNOS, slowing the decay of the ferric-NO species. We 
have also demonstrated that position 134, occupied by a histidine in wild type gsNOS, 
also gates NO release, with smaller residues at this position corresponding to faster 
release rates. Together, these two positions can account for the majority of the differences 
in rate between any two NOS enzymes. 
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Further, we have used a new, more accurate five-state model to fit our data 
showing rapid equilibrium between the bound and unbound NO, and another unidentified 
species. This species has been previously observed in a mammalian enzyme by another 
group. It was called Compound I. The Compound I in cytochromes P450 has a much 
more blue-shifted Soret band with a maximum near 365 nm and it reacts much more 
quickly. It is of note that this species with absorbance at 420 nm has now been observed 
in both turnovers. This species could possibly be some form of the P420 species in NOS, 
which has either lost thiolate ligation or the thiolate has become protonated, becoming a 
neutral thiol ligand. Unfortunately, its exact identity remains uncertain. 
 
7.3 Future Directions 
 Several experiments remain in order to fully characterize the set of mutants 
probing the role of the hydrogen bonding to the axial thiolate. First, redox titrations must 
be conducted with a different chemical titrant. The 3/2+ couple of Ru(acac)3 is too 
positive to determine the potential of the W70F and W70Y mutants. Another reagent, 
such as benzyl viologen with a reduction potential of -374 mV vs. NHE, might prove 
more appropriate for observing the equilibrium between oxidized and reduced species. 
Further, these titrations should be carried in the presence of the substrate arginine as well, 
in order to determine if the presence of substrate shifts the potential as was seen with 
mammalian inducible NOS.  
 The full effect of mutating this hydrogen bond donor cannot be understood until 
structural data is collected. Crystallography would answer questions about the distance of 
each residue from the thiolate and from the porphyrin ring, as well as the positioning of 
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the sulfur atom with respect to the iron for each sample. It would also reveal any other 
unexpected effects on the fold of the protein. Samples have been sent to the lab of Brian 
Crane at Cornell, an expert in NOS crystallography. This family of enzymes, however, is 
notoriously difficult and slow to crystallize. Efforts to obtain these three-dimensional 
structures are underway.  
 Work on protein film voltammetry with gsNOS is still ongoing in the lab of 
Michael Hill at Occidental College. In addition to measuring reduction potentials, the 
interaction of each sample with the axial water ligand will be investigated by studying the 
scan rate dependence. The iron centers will also be probed in the presence of arginine, 
which should shift all potentials and remove any interaction with water at the heme. 
These experiments are expected to be completed within the next couple of months.  
 Finally, electron transfer pathways in NOS should be studied using more 
traditional Gray group laser-induced flash/quench techniques. Attempts have been made 
at connecting a Ru-trisdiimine photosensitizer to the enzyme in order to induce ET 
to/from the heme (see Appendix II). The iodoacetamidophenanthroline ligand should be 
used to tether Ru(bpy)2 to the enzyme at position 115. Initial studies show quenching of 
the Ru excited state and formation of Ru(III), but no oxidation of the heme despite rapid 
loss of the Ru(III). These results suggest that possibly another residue in the enzyme is 
being oxidized. gsNOS has more than a dozen oxidizable Trp and Tyr residues. 
Mutations may be required in order to promote oxidation of the heme center rather than 
another residue. Further studies should be able to produce high-valent heme species in 
this enzyme. The characterization of any high-valent species in NOS would be of 
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Probing the heme-thiolate oxygenase domain of inducible nitric oxide 
synthase with Ru(II) and Re(I) electron tunneling wires 
Charlotte A. Whited, Wendy Belliston-Bittner, Alexander R. Dunn, Jay R. Winkler* and 
Harry B. Gray*  
Beckman Institute, California Institute of Technology, Pasadena, 91125, USA 
  
ABSTRACT: Nitric oxide synthase (NOS) catalyzes the production of nitric oxide from L-
arginine and dioxygen at a thiolate-ligated heme active site.  Although many of the reaction 
intermediates are as yet unidentified, it is well established that the catalytic cycle begins with 
substrate binding and rate-limiting electron transfer to the heme.  Here we show that Ru(II)-
diimine and Re(I)-diimine electron tunneling wires trigger nanosecond photoreduction of the 
active-site heme in the enzyme.  Very rapid generation of a reduced thiolate-ligated heme opens 
the way for direct observation of short-lived intermediates in the NOS reaction cycle.   
 
INTRODUCTION 
 Salvador Moncada and colleagues reported  in 1987 that the molecule responsible for 
relaxation of blood vessels is nitric oxide (NO).1  This publication marked the beginning of a new 
area of chemical and biological research, with thousands of articles published each year. Long 
known as a cytotoxic agent in pathological processes,2 NO now is recognized as a key signaling 
molecule in the cardiovascular, immune, and nervous systems.3  
 Nitric oxide synthases (NOSs) are responsible for the production of NO in living 
systems.4  The three (mammalian) isoforms of the enzyme are named for the tissues in which they 
are found: endothelial NOS (eNOS), neuronal (nNOS), and an inducible form found in 
macrophages (iNOS).  The functions of eNOS and nNOS are regulated by calcium ions and a 
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both the Soret absorption maximum and the heme spin state.7, 17  One-electron reduction of the 
NOS:substrate complex gives a five-coordinate ferrous that readily binds dioxygen, forming a 
ferrous-oxy species (equivalent to ferric superoxide),8 the last observed intermediate in the 
catalytic cycle.8, 18   
The role of pterin has been extensively investigated.11, 16, 19  This molecule binds in a 
pocket alongside the heme, forming hydrogen bonds with a P-IX carboxylate, thereby coupling it 
to the active site.13  It is known that a pterin-based radical forms and is reduced during the 
catalytic cycle, as determined by analysis of results from rapid-freeze EPR experiments.12, 20  
Turnover has never been observed without fully reduced pterin cofactor.21    
The NOS reaction cycle bears many similarities to that of P450s.  P450s contain thiolate-
heme active sites and hydroxylate substrates via two-electron oxidation processes.22, 23  The P450 
cycle also begins with substrate binding followed by heme reduction, dioxygen binding, and 
another reduction step leading to the formation of a high-valent iron-oxo complex (Compound I) 
that hydroxylates the substrate (Scheme 2).23  Separate enzymes serve as reductases for P450s, 
but substrate hydroxylation can be driven using external sources of electrons.24  Owing to these 
similarities, the mechanism of the first turnover of NOS is postulated to be the same as that of 
P450s.25  However, the second turnover, a three-electron oxidation, is thought to employ a unique 
mechanism.26  It has been suggested that a protonated ferric hydroperoxide may act as the 
nucleophile in the second turnover18 rather than Compound I, which is a ferryl P-IX radical 















































Scheme 2: Proposed NOS catalytic cycle; active-site intermediates that have not been observed are shown 
in red. 
 
Steps in the mechanistic cycle borrowed from P450 are shown in Scheme 2.  Although 
several intermediates in the P450 cycle already have been observed, there can be no doubt that 
“the hunt for an unambiguous experimental identification of the ephemeral active oxygen species 
will most certainly continue.”22  If that is the case for P450, then we may conclude that work on 
the NOS catalytic cycle is just beginning.  
A long-standing goal in our group is the development of methods to generate and observe 
high-valent iron-oxo complexes that are believed to play key roles as intermediates in the 
catalytic cycles of heme enzymes.27  Direct observation during turnover would allow definitive 
identification of the active oxidant.  Drawing on studies of similar enzymes and using EPR under 
cryogenic conditions and X-ray crystallography, investigators have amassed a large body of 
evidence that strongly indicates that Compound I (Scheme 2, the ferryl P-IX racial cation shown 
in red) is the active species.28  The steps leading to formation of this highly reactive species are 
slow, making its observation problematic, as at best it is present in very low concentrations 
during catalysis.   
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We have investigated the redox photochemistry of two heme enzymes, microperoxidase-
8 (MP-8, a heme octapeptide fragment of cytochrome c) and horseradish peroxidase (HRP).29  
Visible excitation of Ru(bpy)32+ (bpy is 2,2’-bipyridine) in the presence of oxidative quenchers in 
solution generates a powerful Ru(III)-diimine oxidant, which reacts rapidly with P-IX to form the 
P-IX radical cation, which then oxidizes Fe(III) to give high-valent iron-oxo complexes of MP-8 
and HRP.29, 30  Attempts to generate high-valent hemes in P450s in reactions with uncomplexed 
photogenerated oxidants were not successful so we changed course, as discussed in the following 
section.   
 
CHANNEL-BINDING WIRES 
Since 1999 we have developed sensitizer-linked electron tunneling wires that are able to 
deliver electrons and holes rapidly to and from deeply buried active sites of heme enzymes.31, 32  
Attaching the photosensitizer to the substrate promotes a close interaction between the two, and 
increases the probability of ET (Figure 1).   A selection of such molecules developed for the 
oxygenase domain of iNOS is shown in Chart 1. 
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 We have developed a system in which the heme of inducible nitric oxide synthase can be 
photoreduced rapidly without interfering with substrate or cofactor binding.  Employing flash-
quench experiments with a surface-binding Ru-diimine wire in combination with reductive 
quenchers, we observed ET to the imidazole-bound heme of iNOSoxy fully seven orders of 
magnitude faster than the natural reduction.  This finding represents an important step toward our 
goal of identifying reactive intermediates in the catalytic cycles of heme oxotransferases.   
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AII.1 Introduction and Summary 
The Gray group’s interest in NOS focuses on the nature of the putative high-
valent intermediates in the catalytic cycle. To study these, we have expressed a mutant 
with a single solvent-exposed cysteine residue and attached a ruthenium tris-diimine 
complex as a photosensitizer. We use the Ru complex and a laser-induced flash/quench 
scheme to pull electrons out of the active site to generate high-valent species, which we 
characterize by transient absorption spectroscopy.   
In order to photochemically generate high-valent species of the heme center in 
nitric oxide synthase, mutant forms of the enzyme from Geobacillus stearothermophilus 
were expressed.* The enzyme contains more than a dozen surface-exposed histidine 
residues, so cysteine labeling is the preferred method for attaching the photosensitizer. 
There are four native cysteine residues in gsNOS at positions 76, 161, 227, and 269. 
Cys76 ligates the iron center and is necessary for enzymatic function. Cys161 is fully 
buried within the core of the protein and inaccessible to solution. Positions 227 and 269 
were mutated to serine residues in order to prevent them from interfering with labeling 
reactions. First, a cysteine was installed close to the heme at position 84 (only 8 residues 
from the axial thiolate ligand). This position failed to label. Another position, K115, was 
mutated to a cysteine and this mutant was successfully labeled on two occasions 
(K115C/C227S/C269S). All of these plasmids can be found in the -20 alumni freezer in 
the box labeled Charlotte NOS.  
 The first molecule synthesized for labeling purposes was the photosensitizer 
shown below in Scheme 1. This molecule was attached to the mutant gsNOS protein on 
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with 4 x 25 mL of dichloromethane. The pink color remains in the aqueous fraction. The 
DCM is then rotovapped to give pure product. Yield, 20%. For NMR characterization see 
Strouse et al.  
(2) 0.249 g of the product from (1) was dissolved in 15 mL of methanol. This 
solution was submerged in an ice bath. 6 mL of a solution of 0.2 M NaOH was prepared, 
and 55 mg of sodium borohydride (NaBH4) was added to the NaOH solution. After 
ample time for cooling of the methanol, the borohydride was added dropwise to it. This 
mixture was allowed to stir on ice for a few minutes before removal of the ice bath and 
stirring for another hour at room temperature. The methanol was removed leaving a 
suspension of white solid in the aqueous fraction of the reaction. To this 6 mL of 
saturated Na2CO3 aqueous solution was added. This aqueous mixture was then extracted 
4 times with 15 mL of chloroform. The chloroform was dried using MgSO4 and then 
filtered and rotovapped to yield a white solid in > 90% yield.  
(3) 193.6 mg (0.40 mmol) of cis-dichloroRu(bpy)2 and 100 mg (0.50 mmol) 4-
hydroxymethyl-4’-methylbipyridine (product of (2)) were added to a round bottom flask. 
This was dissolved in 100 mL of water and refluxed for 1 hour. It was then cooled, 
filtered, the liquid collected, and a solution of saturated NH4PF6 (aq.) was used to crash 
out the product. This was filtered and the product dried on a vacuum line.  
(4) Once dry, the product from (3) was dissolved in 10 mL HBr and 1 mL H2SO4 
and refluxed for approximately 5–6 hours. It was cooled and the product was precipitated 
using saturated NH4PF6 (aq.) again to precipitate the product. This was filtered and 
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AII.4 Future Directions 
 This project was abandoned due to poor reproducibility of the labeling reaction 
and the lack of oxidation of the heme, as shown in the laser studies. We now know that 
reproducibility of the labeling reaction can be avoided by using an iodoacetamido-
phenanthroline to label rather than an aryl bromide. See Ener et al., PNAS, 2010, 107, 
18783–18786. A note on synthesis of this new label: isolation was simplified by attaching 
aminophenanthroline to Ru(bpy)2Cl2 first (by a similar procedure used for step (3) 
above), and then mixing this complex with iodoacetic anhydride (1:1) in DCM and 
extracting this with an aqueous solution to remove iodoacetic acid. The product is light 
sensitive, so store it under foil. When this complex is used under the same labeling 





* Attempts were made to photochemically oxidize the heme with Ru(bpy)32+ in the 
presence of both reversible and irreversible oxidative quenchers. In neither case were any 
oxidative products observed, therefore covalent attemchent was deemed necessary. 
 
 
 
